Microfoam generation system with reaction vessel, cartridge and automated system, process and computer program for generating a microfoam
The reaction container with a rotatable foaming element and defined channels addresses the instability issues of existing foams by producing stable microfoams with uniform bubbles, improving safety and efficacy in medical treatments.
Patent Information
- Application Number
- DE102023112792
- Authority / Receiving Office
- DE · DE
- Patent Type
- Applications
- Current Assignee / Owner
- Filing Date
- 2023-05-15
- Publication Date
- 2024-11-21
- Estimated Expiration
- Not applicable · inactive patent
AI Technical Summary
Existing methods for producing medical foams for sclerotherapy face challenges in achieving stable microfoams with uniform bubble sizes due to issues with nitrogen-containing foams leading to complications and carbon dioxide-based foams losing stability quickly, resulting in large gas bubbles that can cause cardiovascular problems.
A reaction container with a rotatable foaming element, positioning element, and defined inlet and outlet channels, along with a magnetic drive, ensures high stability and uniform bubble size by thorough mixing and controlled production of microfoams using gases like CO2 and O2, allowing for precise positioning and efficient waste removal.
The system produces stable microfoams with narrow bubble size distribution, enhancing safety and efficacy in medical treatments by preventing large gas bubbles, enabling controlled and reproducible production suitable for diagnostic and therapeutic applications.
Smart Images

Figure 00000000_0000_ABST
Abstract
Description
[0001] The present invention relates to a reaction vessel for generating a microfoam, a cartridge comprising the reaction vessel, and an automated system accommodating the cartridge for automatically generating a microfoam, preferably a medical microfoam, in particular a sclerotherapy foam for use in sclerotherapy. Furthermore, the invention relates to a method for automatically generating a microfoam, preferably a medical microfoam, in particular a sclerotherapy foam for use in sclerotherapy, as well as a microfoam that can be achieved by the innovative method, and a computer program for use with the automated system.
[0002] In general, a medical-grade foam for use in sclerotherapy is already known in the current state of the art. However, obtaining a medical-grade foam with the desired properties typically requires a complex mixing process. In particular, a small and uniform bubble size that provides a high degree of stability may be desirable.
[0003] Factors that could cause difficulties with the current state of the art may arise from a lack of stability, which may be a consequence of foam bubbles that are either too large or of very heterogeneous size.
[0004] Document US2017 / 144115 discloses a container for producing a foamed sclerosing agent composition, kits and systems containing such a container, and methods for producing a foamed sclerosing agent composition using such containers.
[0005] Prior art document WO2017 / 085209 also relates to a container for producing a foamed sclerosing agent composition, kits and systems containing such a container, methods for producing a foamed sclerosing agent composition using such containers, and further to foamed sclerosing agent compositions obtainable by such methods.
[0006] Document WO2020 / 0389A1 discloses methods, devices, systems and kits for producing compositions for medical treatment and repair of varicose veins.
[0007] Physician-compounded foams (PCFs) were introduced into varicose vein treatment with the intention of achieving greater efficacy and being able to treat larger varicose veins than liquid sclerosants. However, foams are not always the same. In fact, they can vary considerably. The performance of foams depends largely on their physical properties, such as gas composition, the varying absorption rates of nitrogen and carbon dioxide in the bloodstream, and bubble size.
[0008] PCFs offer several advantages over conventional liquid sclerosants. When injected into a vein, a cohesive foam displaces the blood (rather than mixing with it), establishing better contact with the vein wall. Foam treatment offers the possibility of using lower concentrations of sclerosant. This, in turn, increases the safety of foam treatment, as demonstrated in clinical studies. Furthermore, foam is echogenic, which improves visibility and treatment accuracy. Furthermore, foam treatment can be performed on an outpatient basis without the need for sedation or tumescent anesthesia.
[0009] On the other hand, foam treatment is also associated with difficulties. Although room air (RO) forms a stable foam, due to the nitrogen it contains, this foam does not dissolve efficiently in the blood. As a result, nitrogen bubbles can persist, which can cause serious complications such as neurological events or the formation of large gas pockets in the cardiovascular system, such as the right ventricle, patent foramen ovale (PFO), or other right-to-left shunts. These neurological events have been attributed to nitrogen / air as the gas used for foam generation. Foams containing a mixture of carbon dioxide and oxygen have fewer side effects but have the disadvantage that the increased solubility leads to foams that coarsen rapidly, resulting in drastically reduced stability.They also tend to generate large gas bubbles that can cause problems in the bloodstream.
[0010] Despite the great progress in this field, there is still a need for improvements in the production of sclerotherapy foam.
[0011] The present invention is therefore based on the object of enriching and improving the state of the art or providing an alternative to the previous techniques. Brief description of the invention
[0012] This object is achieved by a reaction vessel according to claim 1, a cartridge having the features of claim 16, an automated system having the features of claim 25, a method having the features of claim 36, a microfoam having the features of claim 38, and the computer according to claim 40. Further features and details of the invention are disclosed in the respective dependent claims, the description, and the drawings. Features and details described in connection with the device according to the invention also apply to the system according to the invention, the method according to the invention, the microfoam according to the invention, and the computer program according to the invention, and vice versa, so that reciprocal reference can always be made to the disclosure of the individual aspects of the invention.
[0013] In the first aspect, the invention provides a reaction vessel for producing a microfoam, comprising a vessel body defining a foaming chamber and comprising: a rotatable foaming element arranged in the foaming chamber for carrying out a foaming process to produce the microfoam from a liquid foaming composition, b. a positioning element at the bottom of the foaming chamber, which holds the foaming element so that it can rotate around a predefined axis during the foaming process, c. a first outlet channel arranged adjacent to or at the lower part of the foaming chamber and in flow communication with the foaming chamber for removing the microfoam from the foaming chamber.
[0014] The device according to the invention can have the advantage of producing a microfoam with a high degree of stability, which is particularly advantageous for the use of the microfoam in diagnostic or therapeutic procedures. Due to this high degree of stability, the physician has sufficient time to remove the microfoam from the foaming chamber and administer it to the patient who requires it.
[0015] The microfoam of the invention consists of small bubbles and has a narrow bubble size distribution, which provides high stability and cohesion, allowing for wide use in the treatment and diagnosis of patients who need it.
[0016] With the reaction vessel, the cartridge and the automated system of the invention, the present invention provides a basic technological platform for the highly controlled generation of stable microfoam that can be used in a wide range of applications, such as diagnostic, therapeutic or cosmetic purposes.
[0017] The inventors have discovered that the positioning element allows highly precise positioning of the rotatable foaming element, even in rotation mode. In a preferred embodiment, the rotatable foaming element is magnetically driven by an actuator that does not enter the foaming chamber but is located outside it, for example, a magnetic stirrer. A magnetic drive has the disadvantage that the (unguided) rotatable foaming element can enter a wobbling motion—particularly during acceleration or deceleration phases. The positioning element prevents any wobbling motion. It has been determined that to generate a high-quality microfoam, the rotatable foaming element must maintain a preselected distance from the floor and walls of the foaming chamber during the foaming process. This is achieved by the claimed positioning element.
[0018] The use of a rotatable foaming element that can be driven by an actuator that does not penetrate the foaming chamber and the provision of a reaction vessel with defined inlet and outlet channels allows the production of sterile microfoam as required for diagnostic or therapeutic purposes.
[0019] Thus, the claimed reaction vessel enables the automated and controlled production of a high-quality microfoam in a reproducible manner.
[0020] The reaction vessel can be used with the foaming agents and aqueous diluents established in the state of the art and can thus be used for a wide range of foaming applications.
[0021] The claimed reaction vessel allows foam generation for which relevant parameters such as gas mixing ratios, concentrations of the foaming agent and the aqueous diluent, volume of the microfoam to be generated and the rotation parameters can be easily adapted to the therapeutic requirements.
[0022] The invention in detail: The rotation of the rotating foaming element leads to a thorough mixing of the contents of the foaming chamber, i.e. the diluted foaming agent and the gas or gas mixture, thus generating a microfoam.
[0023] Continuous, thorough mixing is supported by secure positioning of the rotating foaming element, which is a result of the positioning element.
[0024] Preferably, the positioning element is an axis that holds the rotatable foaming element in the previously selected position within the foaming chamber.
[0025] According to the invention, the first outlet channel is arranged adjacent to or at the lower part of the foaming chamber and is in fluid communication with the foaming chamber to remove the microfoam from the foaming chamber. It has been found that the best microfoam is produced in the lower part of the foaming chamber, and removing the microfoam adjacent to or at the bottom of the chamber produces the best results.
[0026] The foaming chamber may have a cylindrical shape or an upwardly tapering conical, truncated cone, hemispherical or dome-like shape, so that most of the capacity is located in the lower part of the foaming chamber in the foam generation area.
[0027] In a preferred embodiment, the foaming chamber has a flat bottom, which is preferably connected to the side wall of the foaming chamber with rounded edges.
[0028] The rounded edges have advantages in terms of cleaning aspects and subsequent cleaning.
[0029] The container body can be made of metal or, preferably, of synthetic material. It can be made of any polymeric material known to those skilled in the art. Preferred polymers include polyacrylates, polyamides, polycarbonates, polyesters, polyimides, vinyl polymers, and halogenated vinyl polymers, such as polytetrafluoroethylene.
[0030] In a preferred embodiment, the container body is made of a biocompatible material according to ISO 10993.
[0031] The foaming chamber preferably has a smooth inner surface to reduce adhesion of the foam components. This property can be determined as surface roughness according to ISO 25178, with the surface preferably having a real roughness value S aof less than 1 mm, preferably less than 0.1 mm, particularly preferably less than 0.01 mm, very particularly preferably less than 0.005 mm and in particular less than 0.001 mm.
[0032] In a preferred embodiment, the reaction vessel of the present invention is characterized by a vessel body defining the foaming chamber, wherein the vessel body further comprises one or more, or preferably all, of the following properties: a first inlet channel which is in flow connection with the foaming chamber in order to supply a gas or gas mixture to the foaming chamber, wherein the first inlet channel is preferably arranged at the upper part of the foaming chamber, b1. a second inlet channel in flow communication with the foaming chamber for supplying a mixture comprising a foaming agent and an aqueous diluent to the foaming chamber, the second inlet channel preferably being arranged adjacent to or at the lower part of the foaming chamber, or b2. a second inlet channel in flow communication with the foaming chamber for supplying an aqueous diluent to the foaming chamber, the second inlet channel preferably being arranged at the upper part of the foaming chamber and being provided together with a third inlet channel in flow communication with the foaming chamber for supplying a foaming agent to the foaming chamber, the third inlet channel preferably being arranged next to or at the lower part of the foaming chamber.
[0033] The first inlet channel allows the supply of a gas or gas mixture, which can be any gas capable of generating foam. The expert selects the appropriate gas or gas mixture based on the specific foam application.
[0034] The gas or gas mixture is preferably a physiological gas, such as CO2 and O2, or a mixture thereof. An increasing amount of CO2 leads to greater absorption by the body, while an increasing amount of O2 increases foam stability. The diameter of the blood vessels to be treated (preferably veins) is an important parameter for defining the CO2 / O2 ratio of the gas mixture. For large-diameter veins, the use of a foam with a high CO2 content is preferred, as it is easier to metabolize yet stable, because the 1% concentration of polidocanol used for large veins provides sufficient surface activity. For small-diameter veins, the use of a high oxygen content is preferred because foam with increased O2-based stability must be used, as the agent concentration can be as low as 0.1%.Because the small-diameter veins are located at the surface, the oxygen has sufficient time to metabolize before entering the general bloodstream. For use in sclerotherapy, a CO2 / O2 gas mixture with a ratio of 20 / 80 to 80 / 20 is preferred. For example, the CO2 / O2 gas mixture ratio can be 20 / 80, 25 / 75, 30 / 70, 35 / 65, 40 / 60, 45 / 55, 50 / 50, 55 / 45, 60 / 40, 65 / 35, 70 / 30, 75 / 25, or 80 / 20.
[0035] The preferred position of the first inlet channel in the upper part of the foaming chamber, especially in combination with an outlet channel next to or in the lower part of the foaming chamber, allows a quick and complete filling of the foaming chamber with the respective gas or gas mixture.
[0036] According to the present invention, the supply of the foaming agent and the aqueous diluent to the foaming chambers can be carried out in two ways: In a first embodiment, the second inlet channel allows the supply of a mixture comprising a foaming agent and an aqueous diluent, which represent the liquid components of the foam to be generated, to the foaming chamber. According to this embodiment, the third inlet channel can be omitted.
[0037] In an alternative embodiment, the second inlet channel is used to supply the aqueous diluent to the provided foaming chamber, together with a third inlet for supplying the foaming agent to the foaming chamber. The second inlet channel is preferably located in the upper part of the foaming chamber. This also allows the foaming chamber to be washed out with the aqueous diluent as initial preparation of the foaming chamber or between two different foaming processes. In this configuration, it is preferred that the third inlet channel is located next to or at the lower part of the foaming chamber. This has the advantage that the entire volume of foaming agent is introduced in the region of the foaming element, where it can be correctly diluted by adding the diluent and rotating the foaming element.
[0038] A foaming agent is a material that promotes foam formation. Surfactants are typically used as foaming agents. When present in small amounts, they reduce the surface tension of a liquid or increase its colloidal stability by preventing bubbles from coalescing.
[0039] In some configurations, the foaming agent can be a mixture of a surfactant and a cosurfactant. Surfactants that are less effective at foaming can have additional cosurfactants added to enhance foaming. In this case, the cosurfactant is referred to as the foaming agent. These are surfactants used in a detergent system at a lower concentration than the primary surfactant and are often from the cocamide family of surfactants.
[0040] Examples of foaming agents that can be used to produce the microfoam include, but are not limited to, phospholipids such as phosphatidylcholine; proteins such as albumin; fatty acid alcohols such as polidocanol; sulfate esters of fatty alcohols such as sodium tetradecyl sulfate (sodium morrhuate); sugar esters such as sucrose stearate, sucrose distearate or sucrose tristearate; block copolymers such as Pluronic F-68 or Pluronic P-123; zonylfluoro surfactants; fatty acids such as stearic acid or oleic acid and their salts such as sodium stearate or potassium oleate.
[0041] In some embodiments, polidocanol is used as a foaming agent. Polidocanol is a synthetic fatty alcohol (hydroxypolyethoxydodecane) with cleaning activity that works via a mechanism known as protein theft denaturation, whereby an aggregation of detergent molecules forms a lipid bilayer that disrupts the cell surface membrane and causes endothelial cell death. Polidocanol induces fibrosis within varicose veins, thereby closing the lumen of the vessel and reducing the appearance of the varicosity. It is therefore used to treat varicose veins, hemangiomas, and vascular malformations.
[0042] With the other necessary components, such as the aqueous diluent and a gas or gas mixture, and in the form of a controlled-release microfoam, it can be administered intravenously in the treatment of varicose veins, hemangiomas and vascular malformations.
[0043] The aqueous diluent provides the aqueous solvent required for micelle formation. Examples of aqueous diluents that can be used to produce the microfoam include water, isotonic saline, citrate buffer, phosphate buffer, acetate buffer, histidine lactate buffer, tromethamine gluconate buffer, aspartate buffer, or Sclerodex (hypertonic saline combined with dextrose). In particular, the microfoam comprises polidocanol as the foaming agent and water or isotonic saline as the diluent. Such a microfoam, generated with O2, CO2, and preferably a mixture thereof, is particularly suitable for use in sclerotherapy.
[0044] The reaction vessel may be characterized by a vessel body defining the foaming chamber and further comprising a second outlet channel in fluid communication with the foaming chamber for removing waste material from the foaming chamber, the second outlet channel preferably being arranged adjacent to or at the lower part of the foaming chamber.
[0045] The use of the second outlet channel for waste disposal allows for cleaning of the foaming chamber. As a result, the reaction vessel can be used for one or more additional foaming processes, preferably with different foaming parameters.
[0046] Since the waste, which is usually in the form of residual foam or liquid, is predominantly concentrated at the bottom of the foaming chamber, it is preferable to position the second outlet channel next to or at the bottom of the foaming chamber. Furthermore, during the diluent washout from the upper part of the foaming chamber, the waste material accumulates in the lower part of the foaming chamber.
[0047] In a preferred embodiment, the container body of the reaction container of the invention further comprises a deflection element for forced deflection, which generates a downward movement of the fluid in the direction of the rotating foaming element during foam formation and is preferably located in the lower part of the foaming chamber.
[0048] The term "baffle element" in this text is defined as an element that forces the fluid flow within the foaming chamber downward toward the rotating foaming element. It has been observed that a conventional stirring process, such as that generated with the rotating foaming element, can cause the formation of multiple layers, so that a thick foam layer at the bottom is covered by a layer of large-pore foam or even residual liquid. The regeneration of these layers hinders the foaming process, and early layer formation during the foaming process can even prevent the generation of a microfoam.The inventors discovered that a forced deflection of the material, through which "fresh material" enters the area of action of the rotating foaming element from above, breaks up the layers and even prevents the formation of layers, thus allowing the rapid and complete conversion of the starting material into a high-quality microfoam.
[0049] The reaction vessel of the present invention advantageously has a container body that is a sealed container body and / or a sterile or sterilizable container body. A "sealed container body" as defined herein is a container body in which the claimed inlet and outlet channels are the only openings, so that the remaining body surface is watertight and gas-tight, thus enabling controlled and sterile foam production.
[0050] In an alternative embodiment, the reaction vessel has an unsealed container body that allows gas exchange with the environment. In this embodiment, it is preferred to carry out the foaming process under a permanent positive pressure to produce a sterile microfoam.
[0051] The sealed reaction vessel can be provided by a container made from a single piece. Alternatively, the reaction vessel can also have a non-removable lid. The term "non-removable lid" as used herein refers to a lid that cannot be removed manually without causing mechanical damage to the reaction vessel. Such a lid is conveniently attached to the container by secure bonding or heat sealing.
[0052] In an alternative embodiment, the sealed reaction vessel may be provided by a container consisting of two or more parts. Accordingly, the reaction vessel may consist of an open vessel closed with a removable lid.
[0053] The reaction container can be sterilized and used for medical purposes, making it suitable as a sterile reaction container.
[0054] In a preferred embodiment, the rotatable foaming element is configured as a disc with mixing elements suitably shaped to generate turbulent flow and arranged around an outer periphery of the disc, wherein the mixing elements comprise one or more of the following elements: vanes, rings, teeth, fins, ribs, wings, arms, fingers, perforated plates, grid structures or an annular coil spring.
[0055] A "disk" as defined in this text is a flat, circular structure that may have a central protrusion. The protrusion is preferably conical, frustoconical, or dome-shaped. On its outer periphery, the disc is equipped with mixing elements that, when rotated, can induce turbulent flow of the components (i.e., the mixture of the foaming agent and the aqueous diluent) within the foaming chamber, leading to their thorough mixing and ultimately to foam formation.
[0056] The disc is advantageously rotationally symmetrical to enable regular, low-wear and unbalance-free rotation.
[0057] The mixing elements are preferably arranged radially.
[0058] In a further embodiment, the mixing elements define a circumferential gap between the rotatable foaming element and the inner surface of the floor or side walls of the foaming chamber.
[0059] It is preferred that the distance between the lower edge of the rotatable foaming element and the floor of the foaming chamber be less than 1 mm, preferably less than 0.75 mm, and particularly preferably a maximum of 0.5 mm. The distance can therefore be 0.5, 0.4, 0.3, or 0.1 mm.
[0060] It is preferred that the distance between the peripheral edge of the rotatable foaming element and the side wall of the foaming chamber is between 0.01 and 5 mm, preferably between 0.5 and 3 mm, particularly preferably between 0.75 mm and 2.5 mm, and most preferably between 1.0 and 2.0 mm. The distance can be, for example, 0.02, 0.05, 0.1, 0.2, 0.3, 0.4, 0.5, 0.6, 0.7, 0.8, 0.9, 1.0, 1.1, 1.2, 1.3, 1.4, 1.5, 1.6, 1.7, 1.8, 1.9, 2.0, 2.5, 3.0, 3.5, 4.0, or 4.5 mm.
[0061] Preferably, the rotatable foaming element of the reaction vessel is configured to be magnetically driven by a magnetic stirrer located outside the foaming chamber, wherein the magnetic stirrer is preferably located below the lower part of the foaming chamber. It is preferred that the rotatable foaming element be a disk.
[0062] As a result, the rotating foaming element is located within the sterile environment of the foaming chamber, eliminating the need to introduce any additional element from the outside. Since the magnetic stirrer does not penetrate the foaming chamber, the risk of foam contamination is virtually eliminated.
[0063] It should be noted that according to the present invention, the rotatable foaming element is configured as a magnetic disk or comprises at least one magnetic element that is magnetically driven by a magnetic stirring device below the foaming chamber.
[0064] The foaming element can be driven by at least one rotating magnet or an array of electromagnets in the magnetic stirring device. It is also conceivable for the magnet to be rotated by a set of coils that generate a rotating magnetic field. The magnets can be integrated into the foaming element, permanently attached to it, or even removable. The magnetic force induced by the magnets can be strong enough to restrict the foaming element's lateral movement during rotation through their magnetic interaction with the magnetic stirring device.
[0065] Preferably, it can be provided that at least two or at least three or at least four or exactly four magnets are integrated into the foaming element, in particular in a circumference of the foaming element, in order to establish a magnetic coupling with at least three or at least four corresponding magnets on a drive shaft of the magnetic stirring device.
[0066] By establishing this magnetic coupling, the transmission of torque through the magnetic field can be advantageously amplified or improved. The magnets on the drive shaft can accordingly be arranged in a circumferential direction around the drive shaft.
[0067] In some configurations, the rotatable foaming element may comprise one or more elements made of soft iron, nickel, or copper, preferably including a soft iron core. Soft iron is a material that can be magnetized in the magnetic field created by the external actuator.
[0068] The rotatable foaming element may be configured to have a centrally located bore, which is preferably open at one end for receiving the positioning element.
[0069] Conveniently, the positioning element is a centrally or off-centered shaft at the bottom of the foaming chamber, which preferably has a cylindrical side wall with a rounded or angled upper corner.
[0070] The centrally positioned shaft, which thus represents a central axis for the rotating foaming element, is preferably positioned centrally in the foaming chamber, allowing for constant gaps between the outer circumference of the disc and the adjacent walls of the foaming chamber. These constant gaps, when correctly dimensioned, also enable an optimal foaming process.
[0071] Based on the second alternative of an off-center shaft, the rotatable foaming element is also positioned off-center in the foaming chamber because it has been found that this further enhances turbulent flow. "Off-center" in this context can describe that the predefined axis does not resemble an imaginary axis extending from the upper region toward the lower region through the geometric center or centroid of the foaming chamber volume in a manner parallel to the direction of gravity when the device is on a flat surface. This flat surface can be oriented perpendicular to the direction of gravity.
[0072] The rotatable foaming element can be simply mounted on the positioning element or otherwise mounted with a bearing.
[0073] It is further conceivable that the positioning element is configured as a stationary, floor-mounted and / or floor-mounted axis for holding the foaming element and preferably comprises a bearing (in particular an axial bearing) of the foaming element. In other words, the stationary axis can hold the foaming element or enable attachment of the foaming element to the stationary axis and further comprise a bearing (in particular an axial bearing). The axis can in particular be a vertical axis suitable for limiting movement of the foaming element in all horizontal directions. The foaming element can comprise flexible material and further comprise a hole whose diameter is slightly smaller than the diameter of the stationary axis to enable a press fit of the stationary axis in the foaming element.The interference fit can be strong enough to limit or completely prevent the translational movement of the foaming element during the foaming process. The fixed axis can provide the technical effect of smooth and consistent rotation of the foaming element.
[0074] In the context of the movement of the foaming element, the term “translational movement” can define a movement of the foaming element along the predefined axis, i.e. perpendicular to the rotational movement of the foaming element.
[0075] In another embodiment, the stationary axis is formed as a continuous axis extending from the bottom to the top of the reaction chamber.
[0076] According to one embodiment of the invention, the reaction vessel may further comprise a restriction element for restricting the upward movement of the rotatable foaming element. This restriction element prevents the foaming element from falling off the positioning element during transport or handling.
[0077] This restriction element is preferably a rod-shaped element which preferably extends from the upper part of the foaming chamber.
[0078] To restrict movement, the restriction element may comprise at least one structural component, such as a wall or protrusion, that blocks the translational movement of the foaming element. However, a certain amount of translational movement may be permitted as long as the foaming element does not leave the positioning element. Therefore, translational movement, for example, in the direction of the predefined axis, may be permitted but limited: Preferably, the movement is only permitted over a distance less than the length of the positioning element.
[0079] The restriction element can be part of the upper section or a separate component of the foaming chamber. It is also conceivable for the restriction element to be the upper section itself. Furthermore, the restriction arrangement can be attached to the upper section or to other parts of the foaming chamber.
[0080] According to an advantageous further development of the invention, it can be provided that the restriction element has a projection, in particular a mandrel, which projects from the upper part of the foaming chamber in order to restrict the movement of the foaming element towards the upper region and / or away from the predefined axis. The projection can be made of plastic and / or have a convex shape towards the foaming element. In other words, the projection can be described as an extension of material extending from the upper region. It can extend completely towards the foaming element in order to directly contact the foaming element, or it can leave a space of at most 20, preferably at most 15, more preferably at most 10, and most preferably at most 5 mm. The space can be, for example, 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18 or 19 mm.
[0081] Within the scope of the invention, it is further conceivable that the restriction element comprises an end stop plate for limiting the movement of the foaming element towards the upper region and / or away from the predefined axis.
[0082] The end stop plate can be arranged at the end of the aforementioned projection. The end stop plate can directly contact the foaming element, in which case the end stop plate can be rotatable along the predefined axis of the foaming element, or it can be arranged at a distance of no more than 5 mm from the foaming element.
[0083] Within the scope of the invention, it is conceivable that the deflection element is a deflection plate or a deflection body arranged in the foaming chamber and / or is a propeller arranged on the rotating foaming element.
[0084] The deflector plate can be shaped as a flat or curved plate, oriented at an angle between 10 and 80 degrees to the horizontal, i.e., the base plate of the foaming chamber. Assuming a uniform direction of rotation, it forms an acute angle with the inlet side of the foaming element, so that the rotation of the foaming element forces the fluids into a downward movement toward the foaming element for direct transport to the mixing elements.
[0085] The angle of the deflection plate can be, for example, 10, 20, 35, 40, 45, 50, 55, 60, 65, 70, 75, or 80 degrees. The angle of the deflection plate is preferably between 40 and 50 degrees.
[0086] The deflector body is a body with a beveled side oriented at an angle of between 10 and 80 degrees to the horizontal, i.e., the base plate. Assuming a consistent direction of rotation, it forms an acute angle with the inlet side of the foaming element, so that the rotation of the foaming element forces the fluids into a downward movement toward the foaming element for direct transport to the mixing elements.
[0087] The angle of the beveled side of the deflection body can be, for example, 10, 20, 35, 40, 45, 50, 55, 60, 65, 70, 75, or 80 degrees. The angle of the beveled side of the deflection body is preferably between 40 and 50 degrees.
[0088] In a preferred embodiment of the invention, the deflection body is a circular ring segment with a trapezoidal basic structure, which has a side beveled towards the bottom of the foaming chamber and a lower horizontal side located above the rotatable foaming element to form a gap between the deflection body and the upper edge of the rotatable foaming element, wherein the circular ring segment is preferably attached to the cylindrical wall of the foaming chamber and more preferably has a radial ring thickness that substantially covers the mixing elements of the rotatable disc.
[0089] Based on a foaming chamber with a circular cross-section, this trapezoidal shape proved advantageous. It should be noted that the above-mentioned circular cross-section refers to a horizontal cross-section of the foaming chamber.
[0090] It is preferred that the gap between the deflection body and the upper edge of the rotating foaming element be less than 2.0 mm, preferably less than 1.5 mm, and particularly preferably less than 1.0 mm. The gap can be, for example, 0.1, 0.2, 0.3, 0.4, 0.5, 0.6, 0.7, 0.8, 0.9, or 1.0 mm. A certain gap is necessary to draw a sufficient amount of material into the rotating foaming element. However, increasing the distance reduces the turbulence of the turbulent flow—and thus also the effectiveness of the foaming process.
[0091] According to an advantageous further development of the invention, it can be provided that the first outlet channel is arranged below the lower horizontal side of the deflection body.
[0092] This arrangement allows for the removal of high-quality microfoam, which has been found to be concentrated in this specific area of the foaming chamber. Furthermore, removing microfoam from this area directly forces the entry of overlying, less dense foam material into the zone of highest flow turbulence, thus maintaining microfoam generation.
[0093] The reaction vessel may further include a gas distribution system that helps evenly distribute the gas or gas mixture entering the foaming chamber from the first inlet channel. This has the advantage of filling the foaming chamber more homogeneously with the gas / gas mixture required for the foaming process and also allows for complete filling without "dead zones" still filled with the previous gas.
[0094] The gas distribution system is preferably designed as a baffle plate or deflector body arranged in the foaming chamber below the first inlet channel to cause a lateral deflection of the gas flow entering the foaming chamber. In this arrangement, the baffle plate or deflector body forms a barrier to the incoming gas or gas mixture and directs it laterally toward the walls and / or lower parts of the foaming chamber.
[0095] In another preferred embodiment, the gas distribution system is provided by a hemispherical, conical, frustoconical, or dome-shaped upper part of the foaming chamber with the first inlet channel at the top to enable a gas flow that is evenly distributed across the horizontal cross-section of the foaming chamber. The inventors have found that the above-described shape of the upper part enables uniform gas distribution.
[0096] The gas distribution system can also be realized by a grid or net through which the gas is passed before or after entering the foaming chamber.
[0097] According to an advantageous further development of the invention, it can be provided that the surface of an upper portion of the foaming chamber is coated with a hydrophobic or superhydrophobic agent or is a morphologically structured (super)hydrophobic surface such as a superamphiphobic, a smooth liquid-infused porous surface (Slippery Liquid-Infused Porous Surface, SLIPS) or a liquid-impregnated surface (LIS).
[0098] This (super)hydrophobic surface reduces or even eliminates the adhesion of liquid components in the upper, "non-functional part" of the foaming chamber, so that virtually all of the material is fed to the rotating foaming element at the bottom, resulting in a highly efficient foaming process. Furthermore, the foaming chamber is easier to clean after foam generation.
[0099] In some embodiments, the reaction vessel includes a pressure equalization device for compensating for pressure fluctuations within the foaming chamber.
[0100] As a result, the pressure equalizing device reduces an overpressure and also increases a negative pressure to maintain the previous reaction pressure within the foaming chamber, whereby the pressure equalizing device stabilizes the pressure within the foaming chamber.
[0101] In one configuration, the pressure equalization device could be provided by a pressure equalization vessel connected to the foaming chamber. In the event of overpressure within the foaming chamber, the gas flows freely from the foaming chamber into the connected pressure equalization vessel, and in the event of negative pressure, the gas flows freely in the opposite direction, i.e., from the connected pressure equalization vessel to the foaming chamber.
[0102] This technical solution has the advantage that it operates within a closed system, thus maintaining the sterility of the foaming chamber.
[0103] In a second aspect, the invention relates to a cartridge containing: a reaction vessel according to the present invention, b. a foam removal port comprising a valve and arranged to be accessible from an outside of the cartridge for removing the generated microfoam, and c. a fluid line coupling the first outlet channel of the foaming chamber to the foam removal port.
[0104] The reaction vessel represents the core element of the cartridge, responsible for foam generation. This reaction vessel, located within the cartridge, has a fluid line connecting the first outlet channel of the foaming chamber to the discharge port. This is the simplest cartridge design and is preferably used with a reaction vessel prefilled with the foaming agent, the aqueous diluent, and the gas or gas mixture.
[0105] In a further option, the foaming chamber can be arranged at least partially or completely within a cartridge body of the device. The cartridge body can be configured as a housing. The cartridge body can be configured to be watertight. It is also possible for the cartridge body to comprise at least one or exactly one of the following materials: plastic, metal, rubber, wood, cardboard, paper, and ceramic. The cartridge body can also comprise a sterilizable surface.
[0106] Integrating the reaction vessel into a cartridge along with a network of fluid lines allows the automation of the foam generation process by installing the cartridge in a specially designed automated system.
[0107] The use of a cartridge has the additional advantage of providing a sterile environment for foam production, i.e. the foaming process.
[0108] The foam dispensing port is accessible from outside the cartridge, allowing for easy removal of the microfoam. The foam dispensing port forms an interface between the cartridge and its surroundings.
[0109] The foam dispensing port contains a valve for safely dispensing the microfoam from the cartridge. This valve can be a one-way valve, ensuring dispensing of the microfoam without compromising the sterile environment in the foaming chamber. Alternatively, it can be a solenoid valve controlled by an electrical circuit that can be connected and / or controlled via a user interface. Preferably, the valve is a Luer cone or Luer lock valve that fits onto the tip of a syringe. In one configuration, the foam dispensing port can comprise a self-sealing valve that opens upon connecting a dispensing device, preferably a syringe.
[0110] The fluid line enables the transport of the microfoam from the first outlet of the foaming chamber to the foam removal port. The fluid line is preferably a water- and gas-tight line. The fluid line can be a hose, a channel, or a pipe. It can be made of or comprised of plastic, rubber, or metal. The fluid line is preferably a flexible hose.
[0111] In a further embodiment, the fluid line comprises a particle filter, which is preferably a sterile filter, to filter the microfoam transported to the foam removal port.
[0112] In case the cartridge has one or more further inlet channels for supplying the aqueous diluent and the foaming agent or a mixture thereof, the cartridge may further comprise: a waste container defining a waste chamber having an inlet for receiving the waste material from the foaming chamber, b. a fluid line coupling the second outlet channel of the foaming chamber to the inlet of the waste container via a valve, and c. wherein the waste container optionally comprises an outlet for pressure relief.
[0113] In a preferred embodiment, the cartridge further contains a waste chamber for receiving the waste material from the foaming chamber. The term "waste material" as used herein refers to a residue of the liquid composition used or a residue of the microfoam generated in the foaming chamber that is not removed. It also includes the washing liquid generated by flushing the foaming chamber with a washing solution, which is preferably the aqueous diluent used to generate the microfoam. By removing the waste material and, if appropriate, the washing liquid, the foaming chamber is made available for a new foaming reaction. This can be useful in a multi-phase foaming process in which at least two microfoam preparations with different concentrations and / or different gas ratios are produced.In the treatment of varicose veins, generating different foams may be necessary for treating veins of different sizes. Furthermore, it is useful in a multi-phase foaming process, where at least two microfoam preparations with identical concentrations and gas ratios are dispensed, as residual foam could hinder the production of the new foam.
[0114] Furthermore, it is advantageous to equip the fluid line with a valve to control the flow of waste material from the foaming chamber to the waste chamber. This valve should be closed during the foaming process and the foam removal phase and opened specifically for waste removal.
[0115] In an optional embodiment, the waste chamber includes an outlet for pressure relief. The pressure relief allows for the reduction of excess pressure created by the waste material entering the waste chamber. In a preferred embodiment, the outlet comprises a particulate filter, preferably a sterile filter, to filter the gas escaping from the waste chamber and / or prevent the outflow of foam.
[0116] In some embodiments, the inlet of the waste container is positioned in the upper part of the waste container, preferably as the upper opening of a hollow shaft, which is preferably positioned in the center of the waste chamber. This elevated position relative to the floor of the waste chamber is a safety measure, as the waste material flows downward to the floor of the waste chamber, so that in the event of a faulty backflow, only gas is transported back to the foaming chamber.
[0117] Furthermore, it is advantageous for the cartridge that the valve for controlling the flow of waste material into the waste chamber is located on the outer surface or accessible from an outer surface of the cartridge and can preferably be controlled by applying external pressure to the valve. The above-mentioned advantages and effects are particularly evident when the cartridge is used in an automated system that allows automatic control of the valve.
[0118] The provision of a valve located on the outer surface of the cartridge lines or accessible from an outer surface of the cartridge lines allows the automation of the foam generation process by installing the cartridge in a specially designed automated system.
[0119] In some configurations, the interior surface of the cartridge's waste chamber is coated with a defoamer or has a morphologically structured, defoaming interior surface, such as a defoaming surface, such as a superamphiphobic surface, a smooth liquid-infused porous surface (SLIPS), or a liquid-impregnated surface (LIS). This has the advantage of eliminating the foam as a component of the waste material and converting it into the liquid portion that accumulates at the bottom of the waste chamber and the gas portion that can be released upon pressure release. As a result, the waste chamber can accommodate much more waste material.
[0120] In some embodiments, the cartridge further comprises: a. a gas supply port having a sealing element and arranged to be accessible from an external side or located on the external surface of the cartridge for supplying a gas or gas mixture; b. a fluid line coupling the gas supply port and the first inlet channel of the foaming chamber.
[0121] The gas supply port allows the supply of the gas or gas mixture required for the foaming process from a gas or gas mixture source located outside the cartridge.
[0122] The fluid line enables the transport of the gas or gas mixture from the gas supply port to the first inlet of the foaming chamber. The fluid line is advantageously a gas-tight line. The fluid line can be a hose, a channel, or a pipe. It can comprise or be made of plastic, rubber, or metal. The fluid line is preferably a flexible hose.
[0123] In a preferred embodiment, the fluid line comprises a particle filter, which is preferably a sterile filter, to filter the gas or gas mixture transported to the foaming chamber.
[0124] The provision of a gas supply port located on the outer surface of the cartridge lines or accessible from an outer surface of the cartridge lines allows the automation of the foam generation process by installing the cartridge in a specially designed automated system.
[0125] It should be noted that according to the present invention, the cartridge further comprises: a diluent supply port having a sealing element and arranged to be accessible from an exterior of the cartridge for supplying an aqueous diluent, b. a fluid line coupling the diluent port and the second inlet channel of the foaming chamber, c. a foaming agent reservoir, which is preferably a syringe and enables a fluid-tight seal with the third inlet channel and preferably also with a foaming agent reservoir port.
[0126] The diluent supply port allows the supply of the aqueous diluent required for the foaming process from a source of aqueous diluent located external to the cartridge. Preferably, the aqueous diluent is water or an isotonic saline solution. These solutions are conveniently provided in an infusion bag and / or infusion bottle located external to the device.
[0127] The fluid line enables the transport of the diluent from the diluent supply port to the second inlet of the foaming chamber. Conveniently, the fluid line is a watertight line. The fluid line may be a hose, a channel, or a pipe. It may comprise or be made of plastic, rubber, or metal. Preferably, the fluid line is a flexible hose.
[0128] In a preferred embodiment, the fluid line comprises a particle filter, which is preferably a sterile filter, to filter the aqueous diluent transported to the foaming chamber.
[0129] The foaming agent reservoir may contain the foaming agent required for the foaming process, which must be diluted with the aqueous diluent to generate the final foaming solution.
[0130] In one configuration, the foaming agent reservoir is prefilled with the selected foaming agent to be transported through the fluid line to the third inlet channel of the foaming chamber and diluted with the aqueous diluent within the foaming chamber.
[0131] In an alternative configuration, the foaming agent reservoir can be filled via the foaming agent reservoir port.
[0132] Preferably, the foaming agent reservoir is a syringe installed in the cartridge, which can be easily filled by filling the syringe from the outside and thus by pulling the plunger and can be emptied in a controlled manner by pressing the plunger over a defined distance.
[0133] The provision of a diluent supply port located on the external surface of the cartridge lines or accessible from an external surface of the cartridge lines allows the automation of the foam generation process by installing the cartridge in a specially designed automated system.
[0134] In some embodiments, the cartridge further comprises: a foaming agent supply port having a valve and arranged to be accessible from an exterior side of the cartridge for supplying a foaming agent, b. a fluid line coupling the foaming agent supply port to the foaming agent reservoir port and to the third inlet channel of the foaming chamber, wherein the fluid line comprises a valve that can be positioned to enable fluid communication of the foaming agent reservoir port with the foaming agent supply port or, alternatively, of the foaming agent reservoir port with the third inlet channel, and wherein the valve can preferably be switched by applying external pressure to the cartridge.
[0135] The foaming agent supply port allows the supply of the foaming agent required for the foaming process from a foaming agent source located outside the cartridge. The foaming agent is preferably a sclerosing agent, for example, polidocanol. The foaming agent is conveniently supplied via a syringe filled with the foaming agent and injected through the valve of the foaming agent supply port.
[0136] The fluid line enables the transport of the foaming agent from the foaming agent supply port to the foaming agent reservoir port and also enables transport from the foaming agent reservoir to the third inlet channel of the foaming chamber. Conveniently, the fluid line is a watertight line. The fluid line can be a hose, a channel, or a pipe. It can comprise or be made of plastic, rubber, or metal. Preferably, the fluid line is a flexible hose.
[0137] It should be noted that the two liquid flows mentioned above act in a complementary manner in that the flow of the foaming agent from the foaming agent supply port to the foaming agent reservoir port excludes the transport from the foaming agent reservoir to the third inlet channel of the foaming chamber and vice versa.
[0138] This can be achieved by the valve located in the fluid line, which can be positioned to allow flow communication between the foaming agent reservoir port and the foaming agent supply port or alternatively between the foaming agent reservoir port and the third inlet channel, wherein the valve can preferably be switched by applying external pressure to the cartridge.
[0139] The provision of a foaming agent supply port located on the outer surface of the cartridge lines or accessible from an outer surface of the cartridge lines allows the automation of the foam generation process by installing the cartridge in a specially designed automated system.
[0140] The foaming agent reservoir, which is preferably a syringe, may be capable of storing at least 4 ml of foaming agent solution.
[0141] In general, it is preferable that the cartridge further comprises a means for uniquely identifying the cartridge and / or its properties, wherein said identification means is preferably selected from an RFID transponder, a barcode, a data matrix code, a QR code or a similar code.
[0142] The unique identifier may contain at least one of the following information: compatibility information, type information, authenticity information, cartridge expiration dates, a production date, a usage status, and a batch and / or serial number. The identification means may be provided via an RFID chip. In this case, the automated system may further comprise an RFID reader. In the context of the invention, RFID may stand for "Radio-Frequency Identification." In the case of a barcode, data matrix code, or QR code, the automated system may comprise a corresponding code reader.
[0143] It is also advantageous if the cartridge of the present invention is configured as a disposable cartridge for use in a medical device and / or a laboratory device, in particular in the automated system according to the invention.
[0144] The cartridge, which is configured as a disposable cartridge, may have the technical benefit of preventing the transfer of contamination from one patient to the next.
[0145] In some embodiments, the cartridge includes a pressure equalization device for compensating for pressure transients in the pressure within the foaming chamber.
[0146] As a result, the pressure equalization device reduces overpressure and also increases negative pressure to maintain the reaction pressure within the foaming chamber.
[0147] The pressure equalization device can be implemented by a pressure sensor in the gas supply line system, which is designed to open a pressure relief valve in case of overpressure or to open the valve to increase the gas flow in case of underpressure.
[0148] In an alternative embodiment, the pressure equalization device could be provided by providing a pressure equalization vessel within the cartridge that is in fluid communication with the foaming chamber. In the event of overpressure within the foaming chamber, the gas flows freely from the foaming chamber into the connected pressure equalization vessel, and in the event of negative pressure, the gas flows freely from the connected pressure equalization vessel to the foaming chamber.
[0149] Both technical solutions have the advantage that they work within the closed system, thus maintaining the sterility of the foaming chamber.
[0150] In a third aspect, the invention provides an automated system for generating microfoam, comprising: a cartridge holder designed to hold a replaceable cartridge according to the invention, b. a magnetic stirrer located below the cartridge for generating a rotating magnetic field to control the rotation of the foaming element around the positioning element.
[0151] The above-mentioned advantages and effects of the cartridge are particularly evident when the cartridge is used in conjunction with an automated system.
[0152] In this configuration, the cartridge represents the core element of the automated system, responsible for foam generation. The automated system includes the chemicals required for the foaming process, such as gas or gases and the aqueous diluent. It is equipped to supply the required quantities to the cartridge based on specific parameters selected by the user.
[0153] The automated system uses a cartridge holder to hold and secure the cartridge so that the chemicals can be delivered in a reliable and safe manner.
[0154] The automated system may further comprise a magnetic stirrer arranged below the cartridge in such a manner as to control the rotation of the foaming element about the positioning element.
[0155] The automated system can be used to produce medical-grade microfoam with different properties, defined, for example, by different foam concentrations and / or a different gas mixture ratio. The results of such processes for producing medical-grade foam can be considered pharmaceutical preparations, which normally require preparation by a licensed pharmacist for use in medical applications. However, the use of a validated automated system eliminates the need for a pharmacist, allowing clinicians to produce the medical-grade microfoam themselves according to their requirements.
[0156] The magnetic stirrer may comprise at least one rotating magnet or an array of electromagnets or a set of coils for generating the rotating magnetic field. The system according to the invention may comprise a power supply device that provides an electrical supply for the system, in particular a supply voltage. The supply voltage may be in the range of 90 V to 400 V, and preferably in the range of 90 V to 260 V.
[0157] The automated system can be configured as a standalone system so that it can perform its function without additional devices. It can also comprise a modular design. Furthermore, it can have interfaces for communication and / or configuration of the foaming parameters, such as a WLAN interface (where WLAN stands for Wireless Local Area Network) or a Bluetooth interface. The system can further comprise a serial interface, in particular a USB interface, which is preferably located in a position that is easily accessible to a user when working with the system. It is also conceivable for the system to comprise an NFC (Near Field Communication) interface or an RFID (Radio Frequency Identification) interface, for example to allow user identification or configuration of the foaming parameters.
[0158] It is possible for the system according to the invention to comprise at least one storage compartment for at least one or at least two or at least three containers, wherein in particular each of the containers stores a quantity of a consumable. The consumables stored in the storage compartment (for example, a liquid composition, a diluent, an agent solution, a gas, or a gas mixture) can be sufficient for at least 20, preferably at least 40, in particular at least 50 consecutive foaming processes.
[0159] It is further conceivable that the automated system comprises at least one sensor for detecting the presence of at least one component of the liquid composition or the liquid composition as a whole or the consumables, as described above. The at least one sensor may be an optical sensor, an ultrasonic sensor, or a weight sensor and may be configured such that detection of the presence of the at least one component of the liquid composition or the liquid composition as a whole can be performed by monitoring at least one pipe of the system in which at least one of the fluids is transported.
[0160] The components of the liquid composition can be selected as at least one of the following: a foaming agent and a suitable solvent, i.e., an aqueous diluent. The consumable can be selected as at least one of the following: a liquid composition, a diluent, a foaming agent, a gas, or gas mixture, wherein the diluent can be sterile water (especially distilled water) or physiological saline, the foaming agent can be polidocanol, sodium tetradecyl sulfate, albumin, or phospholipids, and the at least one gas can be O2 or CO2.
[0161] It should be noted that according to the invention, the cartridge holder of the automated system has a gas inlet port configured to come into fluid communication with the gas supply port of the cartridge in the holder, thereby forming a gas-tight seal between both ports, wherein the gas inlet port of the automated system preferably has a safety valve that allows gas supply only when the cartridge is properly locked in the cartridge holder.
[0162] Conveniently, the cartridge holder of the automated system comprises a diluent introduction port configured to enter into fluid communication with the diluent supply port of the cartridge inserted into the holder, thereby creating a fluid-tight seal between both ports, wherein the diluent introduction port or the system preferably comprises a safety valve that allows diluent supply only when the cartridge is properly locked in the cartridge holder.
[0163] In some configurations, the automated system includes a sensor configured to detect, within the cartridge, the presence or flow of a liquid in the fluid line connecting the diluent port and the second inlet channel of the foaming chamber, wherein the sensor is preferably a capacitive sensor, an optical sensor, or an ultrasonic sensor.
[0164] Preferably, the sensor is arranged below the cartridge in a position below or near the fluid line in order to be in the immediate vicinity of the fluid line.
[0165] In some embodiments, the cartridge holder of the automated system comprises one or more guide elements for properly inserting the cartridge into the cartridge holder, wherein the guide elements preferably comprise at least two retractable elements arranged on the bottom of the cartridge holder and fitting onto respective openings of the cartridge housing.
[0166] In some embodiments, the cartridge holder of the automated system includes a securing mechanism configured to secure the cartridge to the cartridge holder, wherein the securing mechanism preferably includes one or more members disposed in the side wall of the cartridge holder and extendable to engage respective members of the cartridge housing.
[0167] It should be noted that according to the invention, the automated system comprises a gas supply system comprising: a. at least one gas port for connection to at least one gas container, which is preferably a gas cylinder, b. at least one gas line connecting the at least one gas port to the gas supply port via a valve for regulating the gas flow; c. optionally a pressure compensation device to compensate for pressure transients in the pressure within the foaming chamber.
[0168] The gas supply system supplies the cartridge with gases from the gas container(s).
[0169] The gas line enables the transport of the gas from the at least one gas container to the gas supply. The gas line is expediently a gas-tight line. The gas line can be a hose, a duct, or a pipe. It can comprise or be made of plastic, rubber, or metal. The gas line is preferably a flexible hose.
[0170] In an optional embodiment, the gas supply system includes a pressure compensation device (PCD) for compensating for pressure transients within the foaming chamber. The PCD reduces overpressure and also increases negative pressure to maintain the reaction pressure within the foaming chamber.
[0171] The pressure compensation device may be provided by a pressure sensor in the gas supply system, which is designed to open a pressure relief valve in the event of overpressure or to open the valve to increase the gas flow in the event of underpressure.
[0172] In an alternative embodiment, the pressure equalization device could be provided by providing a pressure equalization vessel that is in fluid communication with the foaming chamber. In the event of overpressure within the foaming chamber, the gas flows freely from the foaming chamber into the connected pressure equalization vessel, and in the event of negative pressure, the gas flows freely from the connected pressure equalization vessel to the foaming chamber.
[0173] Both technical solutions have the advantage that they work within the closed system, thus maintaining the sterility of the foaming chamber.
[0174] In some embodiments, the gas supply system also includes a safety valve that automatically interrupts the gas supply in the event of an unacceptable pressure drop.
[0175] In some embodiments, the gas supply system of the automated system comprises: a. two gas ports for connection to two gas containers containing different gases, preferably installed in the automatic system, and particularly preferably an O2 gas container and a CO2 gas container, b. a gas duct network between the two gas ports and the gas inlet port, c. a gas mixing device for mixing the two different gases in a selectable ratio.
[0176] This configuration of the gas supply system provides a gas mixture and transports it from the gas cylinders to the cartridge via a gas duct network.
[0177] In a preferred embodiment, the gas supply system includes a gas container that provides oxygen and a gas container that provides carbon dioxide.
[0178] The gas duct network enables the transport of gas from the two gas containers connected to the two gas ports to the gas inlet. The gas duct network is preferably gas-tight. The gas duct network can be constructed from hoses, ducts, or pipes. They can be made of or comprised of plastic, rubber, or metal. The gas duct network is preferably constructed from flexible hoses.
[0179] In this embodiment of the gas supply system, the gas coming from the two gas containers is mixed in the gas mixing device at a selectable gas ratio and then passed to the gas inlet port of the automated system. After proper positioning of a cartridge according to the invention, the gas mixture is transported via the cartridge's gas supply port and the gas line to the foaming chamber for pre-equilibration of the chamber, for the foaming process, or for subsequent foaming processes.
[0180] The gases can be supplied from independent—preferably disposable—containers and mixed according to the configured gas mixing ratio. The configuration of the gas mixing ratio can be performed by a user via a user interface. The gas supply line can comprise at least one sensor for determining a gas quantity for supplying the gas mixture. If the gas container comprises a storage medium, such as a canister or a cylinder, the gas quantity can be determined using a weight sensor, such as a load cell, for measuring the weight of the canister or cylinder. It is also conceivable to use an ultrasonic sensor to determine the gas quantity in the storage medium. Another possibility for enabling the mixing of the gases according to a desired ratio would be the use of a gas flow meter to determine a gas quantity per unit time.Another alternative would be to use a pressure sensor to calculate the remaining gas quantity. The sensors described above can be part of the automated system, and in particular the gas supply system according to the invention.
[0181] In some embodiments, the automated system comprises a diluent delivery system comprising: a diluent port for connection to a diluent container, preferably installed in the automated system, and b. a fluid line connecting the diluent port to the diluent introduction port via gravity or a pump capable of transporting the diluent from the diluent reservoir to the diluent introduction port.
[0182] The diluent supply system allows the supply of the aqueous diluent from the diluent reservoir, which is preferably installed in the automated system, to the diluent introduction port. After proper installation of a cartridge according to the invention, the diluent is transported via the cartridge's diluent supply port and the fluid line to the foaming chamber for pre-equilibration of the chamber, for the foaming process, or for post-foaming processes (such as cleaning).
[0183] The diluent can be transported by gravity. In the case of an infusion bag, this can be achieved by placing the bag and / or bottle in an elevated position.
[0184] In an alternative configuration, the diluent is transported by a pump installed in the diluent supply system. A peristaltic pump is preferred for this purpose.
[0185] In a further alternative, the diluent transport is accomplished by a pressure medium installed in the diluent supply system and exerting a controlled pressure on a flexible diluent container.
[0186] The aqueous diluent is preferably water or isotonic saline. These solutions are conveniently provided via an infusion bag filled with water or isotonic saline, which bag is preferably installed in the automated system.
[0187] The fluid line enables the transport of the diluent from the diluent port to the diluent introduction port. The fluid line is preferably a watertight line. The fluid line can be a hose, a duct, or a pipe. It can comprise or be made of plastic, rubber, or metal. The fluid line is preferably a flexible hose.
[0188] In a preferred embodiment, the fluid line comprises a particulate filter, which is preferably a sterile filter, to filter the aqueous diluent transported to the diluent introduction port.
[0189] The automated system can use the diluent from a replaceable container to generate the foam diluent in various concentrations. The automated system according to the invention can therefore further comprise at least one sensor for determining the amount of diluent present in the replaceable container, such as a weight or ultrasonic sensor. It is also conceivable that the amount of diluent transported through the diluent supply line is determined by a flow sensor.
[0190] In one embodiment, these ports can be arranged as self-sealing transfer ports, in particular in the form of an opening valve. The term "self-sealing" describes in particular that the transfer port, in particular the opening valve, seals itself watertight when neither removal nor supply is taking place. The term "opening valve" (a valve that is "normally closed") can describe that the valve is closed as long as no transfer of the at least one component takes place.
[0191] In some embodiments, the automated system comprises a syringe-connected delivery system including a drive unit for moving an agitator and capable of performing at least one of the following actions: a. Detecting the correct connection of the inserted syringe to the foam reservoir port of the holding element, b. Detecting the filling of the syringe via the foaming agent reservoir port by detecting the position of the piston, c. Supplying a specific amount of the foaming agent to the foaming chamber by pressing the plunger of the syringe containing the foaming agent by a controlled amount, d. optional detection of syringe malfunctions by determining the amount of pressure to be applied to the syringe plunger.
[0192] The above-mentioned advantages and effects of a syringe installed in the cartridge as a foaming agent reservoir are particularly evident when combined with the configuration of the automated system described above.
[0193] By detecting the correct connection of the inserted syringe to the foaming agent reservoir port of the holding element, the automated system ensures the correct installation of the foaming agent reservoir, which represents an important test after the installation of the cartridge within the automated system.
[0194] By detecting the position of the plunger, the automated system can detect the filling status of the syringe being filled via the foaming agent reservoir port.
[0195] In a subsequent process step, the automated system can push the plunger of the syringe containing foaming agent by a controlled amount to supply a specific amount of foaming agent to the foaming chamber.
[0196] In an optional embodiment, the automated system may detect syringe malfunctions by determining the amount of pressure to be applied to the syringe plunger.
[0197] In some embodiments, the automated system further comprises: a. a control computer in which the control program is located and which is connected to a user interface for controlling the foaming process, in particular by configuring at least one parameter of the foaming process and / or by initiating the foaming process, wherein at least one parameter is selected directly or indirectly from the following: i. a gas concentration, ii. a mixing ratio of the gas mixture, iii. a concentration of the foaming agent in the mixture of foaming agent and diluent, iv. the total amount of the mixture of foaming agent and diluent, a selection of the liquid composition, v. the speed and rotation time of the rotating foaming element, vi. removing waste material from the foaming chamber, vii. cleaning the foaming chamber in preparation for another foaming process, viii. removing the cartridge from the cartridge holder, ix. the period of gas flow; x. the definition of ramps for increasing or decreasing the speed;wherein the automated system is configured to automatically carry out the foaming process based on the configured parameter, and in particular to automatically carry out the mixing of the gases according to the configured mixing ratio of the gas mixture.
[0198] It is understood that the microfoam can be produced automatically by the automated system according to the invention. For example, it can be provided that only at least one parameter of the foaming process is manually configured and / or the foaming process is started manually and then the foaming process continues automatically. Production can therefore take place entirely or at least partially automatically. The term "automatic" can refer to the process of producing the microfoam, i.e., the foaming process, and describe the fact that neither intervention nor action by a user is required while the microfoam is being produced and / or the foaming process is taking place. The composition and / or concentration of the gases and the mixing of the gases and the agent solution can also take place automatically.It is also possible for the concentration of the gases and the agent solution to be adjusted automatically depending on a user selection of predefined presets or scenarios.
[0199] The automated system can be configured to automatically perform the foaming process based on the configured parameter, and in particular to automatically perform the mixing of the gases according to the configured mixing ratio of the gas mixture. For automated execution, at least one or more predefined process flows can be stored in a non-volatile memory of a control arrangement. The control arrangement can further comprise a control unit, which in particular has a processor or the like and is configured to perform the following steps: - Reading of at least one predefined process flow, and / or - Parameterize the process flow using the configured parameter, and / or - Controlling the rotation of the foaming element and / or controlling the mixing of the gases according to the configured process flow.
[0200] The user interface may comprise several components to allow interaction with the user, such as a screen and a graphical user interface on the screen. The user interface may comprise a graphical screen, in particular a touch screen—preferably with capacitive touch input as the primary means of interaction with the user. Alternatively or additionally, it may comprise mechanical keys and / or a keyboard and / or a mouse. The graphical screen may have a diagonal of at least 8 inches, in particular of at least 10 inches. The user interface may further comprise at least one loudspeaker to provide acoustic information or guidance regarding the foaming process. It may further comprise at least one microphone to enable voice control of the user interface and / or an optical signaling device, such as LEDs.
[0201] Preferably, in the context of the invention, it can be provided that the system further comprises: - a control arrangement for initiating a transport of at least one component for the liquid composition to the foaming chamber depending on at least one parameter of the foaming process, wherein at least two or at least three different components are provided, wherein a mixing ratio of the components is set by the at least one parameter and is controlled by the control arrangement, - a user interface for configuring the at least one parameter and / or for activating the control arrangement.
[0202] The control arrangement may comprise an electrical circuit that controls at least one transport element, for example a valve, for initiating the transport, wherein the valve may be a solenoid valve. The control arrangement may further or alternatively comprise mechanical components, such as a pump or a flap, for initiating the transport. To control the mixing ratios of the components of the foaming process and to initiate the transport depending on the at least one parameter of the foaming process, the control arrangement may further comprise at least one sensor, for example a weight sensor or flow sensor that measures the weight of a gas, or a pressure sensor for calculating the flow of a gas or liquid, or may be connected to such a sensor.The control arrangement may further comprise a computer, in particular a microcomputer, to interpret data from the at least one sensor and / or to initiate the transport of the at least one component for the liquid composition.
[0203] It is also possible for the control arrangement to be configured to control the foaming process, in particular a rotation of the foaming element, preferably a speed and / or a starting of the rotation and / or a stopping of the rotation and / or a duration of the rotation. Therefore, the speed and / or the duration of the rotation can be parameters of the foaming process that can be set and / or modified automatically by the control arrangement and / or by means of a manual configuration via the user interface. It is also possible for the foaming process to be carried out using different speeds within a single foaming process, such that a change in the speed is controlled by the control arrangement without stopping the rotation. It is also possible for different foaming processes to be carried out at different speeds.
[0204] Furthermore, within the scope of the invention, it may be advantageous for the device to be configured as a replaceable cartridge that is placed in a cartridge inlet above the stirrer. The system may therefore comprise a means that allows user-initiated removal and attachment of the device, preferably located at least partially within the cartridge inlet. It is conceivable that this means is implemented by a release button or lever that can release the device, for example, by opening hooks designed to hold the device.
[0205] It is possible that the system further includes: - a replaceable container for providing a diluent for the liquid composition, - at least one interchangeable container for providing a foaming gas or at least two interchangeable containers for providing different mixtures of the gases.
[0206] If the supply of different mixtures of gases is intended, the gases can be stored in separate containers and then mixed in the desired ratio. The at least one replaceable container can be made of recyclable material or be made entirely of it.
[0207] Furthermore, it is conceivable that the automated system according to the invention is configured to perform the foaming process automatically and repeatedly as long as the foaming agent solution is available in the foaming agent reservoir. This can be accomplished by monitoring the amount of foaming agent in the agent reservoir, for example, using a sensor. Alternatively, this can be accomplished by predefined parameters, such as specific time periods. In general, the automated system according to the invention can provide a monitoring system for monitoring the amount of at least one consumable (for example, gas or gases, foaming agent, and / or aqueous diluent). The monitoring system can provide at least one sensor.This can provide the technical benefit that the automated system according to the invention can operate at least partially without the need for supervision by qualified personnel. It is possible for the monitoring system to issue a warning to the user via a user interface if one of the consumables falls below a defined threshold. Alternatively or additionally, the warning can be issued as a tone or noise. It is further possible for the monitoring system to limit the use of the device beyond a certain period of time or a certain number of foaming cycles in order to ensure sterile conditions. In this case, a corresponding message can be issued via the user interface or as a tone or noise.
[0208] Furthermore, it can be provided that the automated system is configured to be used in sclerotherapy or for the treatment of other vascular diseases, wherein the device is configured in particular as a laboratory device.
[0209] In a preferred embodiment, the automated system is configured as a mobile system, for example, equipped with wheels, so that the automated system can be moved to the patient who needs it. As a result, it could be used locally (for example, next to the bed), allowing convenient medical preparation of foam for therapeutic or diagnostic purposes.
[0210] Optionally, it is also conceivable that the automated system according to the invention is configured as a laboratory device for the automatic production of the microfoam, preferably a medical microfoam for use in an invasive or minimally invasive medical procedure.
[0211] The automated system is suitable for clinical use and / or use in a laboratory environment and may therefore include appropriate adaptations such as a disinfectable housing or the like. The housing may be designed to withstand cleaning of its outer surface with appropriate cleaning and / or disinfectant agents, such as 4% sodium hypochlorite solution and / or 70% ethanol.
[0212] In a fourth aspect, the invention relates to a method for the automated production of a microfoam, comprising the following steps: a. Providing the reaction vessel according to the present invention, b. optionally flushing the foaming chamber with a selected gas or gas mixture or washing the foaming chamber with the aqueous diluent, preferably saline solution, c. Introducing the selected gas or gas mixture into the foaming chamber via the first inlet channel, d. Introducing a mixture of the foaming agent and the aqueous diluent into the foaming chamber via the second inlet channel, or alternatively introducing the aqueous diluent into the foaming chamber via the second inlet channel and the foaming agent into the foaming chamber via the third inlet channel, e. Rotate the magnetic stirrer to rotate the foaming element until a suitable microfoam is obtained, f. Removing the resulting therapeutic foam from the foaming chamber via the first outlet channel.
[0213] Thus, the method according to the invention realizes the same advantages as have been described in detail with regard to the reaction vessel, the cartridge and the automated system.
[0214] Furthermore, the method can be adapted to be carried out using the automated system and / or the computer program according to the invention to produce the microfoam according to the invention. The preceding steps of the method according to the invention can be carried out sequentially or in any desired order, and individual steps can also be carried out repeatedly.
[0215] Simply put, according to the method of the invention, the microfoam can be produced from the liquid composition comprising the foaming agent and the aqueous diluent and the gas or gas mixture by utilizing the rotation of the foaming element located in the device, which rotates around the positioning element as a predefined axis. Furthermore, the duration, as a parameter of the foaming process, can range from 10 s to 60 s, in particular from 30 s to 50 s. The rotational speed of the foaming element during the foaming process can be between 1,000 rpm and 5,000 rpm, and preferably between 400 rpm and 2,000 rpm. It is possible for the foaming process to produce an amount of at least or exactly 20 ml of microfoam. The method can further comprise washing the foaming chamber after and / or before performing the foaming process.If a multi-phase process is being conducted, the washout can be performed before and / or after each foaming cycle. A diluent, such as saline solution, can be used for the washout.
[0216] Based on 5 ml of foaming liquid (= volume of foaming agent diluted with the aqueous diluent), approximately 40 ml to 45 ml of removable microfoam can be produced.
[0217] With regard to step e., it is preferable to increase the speed during the foaming steps - preferably over several steps with ramps in which the speed is changed, between 5 s and 20 s.
[0218] A preferred protocol includes the following steps: - Ramp from 0 to 2,000 rpm in 10 seconds, - Hold at 2,000 rpm for 20 seconds (pre-foaming), - Ramp from 2,000 rpm to 4,000 rpm in 10 seconds, - Hold at 4,000 rpm for 40 seconds (main foaming phase), - Maintain speed between 2,000 rpm and 4,000 rpm for foam extraction for up to several minutes.
[0219] Preferably, in the context of the invention, the method may comprise the following steps: a. Inserting a cartridge according to the present invention into the cartridge holder of the automated system according to the present invention, b. Selecting a foaming agent concentration using a user interface, c. Selecting a ratio for the mixture of two gases using a user interface, d. Filling the foaming agent reservoir by injecting a foaming agent through the sealing element of the foaming agent supply port, e. Starting the foam generation process using a user interface so that the system automatically rotates the magnetic stirrer to rotate the foaming element in the foaming chamber of the cartridge until a suitable microfoam is obtained, f. once the foam has been generated, remove the microfoam by pulling on the foam dispensing port of the cartridge, g. optional initiation of a cleaning process of the foaming chamber using a user interface, h. optionally repeating the process according to steps a. to g.
[0220] The method may further comprise selecting a system language via the user interface. The method may further comprise selecting at least one foaming profile using the user interface. Each of the provided foaming profiles may comprise a preset configuration for the agent concentration and / or the gas ratio. In addition, the method may comprise outputting instructions for foam production depending on the selected foaming profile via the user interface. The output of the instructions may be via a graphical screen or a speaker. The output of the instructions may be in the previously selected language. The cartridge inlet may be configured to hold the cartridge in place while it is attached. It may further be provided that the cartridge can be released via user interaction.A clamp, plug, or snap connection can be provided for this release. Therefore, the method can further comprise the steps of attaching and detaching the cartridge in and from the cartridge inlet. It is also possible for the method to further comprise the step of detecting when a cartridge is connected. It can further be provided that a cartridge information record is read, which can include at least one of the following information: compatibility information, type information, authenticity information, a cartridge expiration date, and a batch and / or serial number. This can have the technical benefit of detecting counterfeit or previously used cartridges. The cartridge information record can be provided via an RFID chip. In this case, the automated system according to the invention can further comprise an RFID reading device.The step in which the mixture of gases and the agent solution concentration are automatically transferred to the foaming chamber according to the configured gas ratio and agent concentration can proceed as follows: The mixing processes can be controlled by a programmed sequence depending on the configured gas ratio and agent concentration. Software of the system according to the invention can calculate required volumes, which can then be transported via volumetric pumps. The volumes can be determined by the number of pump drive steps or the pumping time, with each step preferably corresponding to a known volume. A linear pump arrangement can be used to provide the agent. A rotating pump, in particular a peristaltic pump, with a tube can be used to provide a diluent for the liquid composition.Both pumps can be driven by stepper motors.
[0221] It is conceivable that the procedure further includes: - initiating a preservation process after the foaming process has been carried out, wherein a rotation of the foaming element is carried out, in particular a slower rotation than in the foaming process, in order to keep the microfoam in a state that allows an application of the microfoam to a patient.
[0222] An electronic or mechanical trigger can be used to initiate the preservation process, which is activated when the foaming process is complete. It is also possible for the preservation process to be initiated after a certain time has elapsed, which has been calculated or specified for the duration of the foaming process. The preservation process can be used to maintain the quality of the foam by extending the time window in which the microfoam is in a state that allows its application to a patient—in other words, in a state in which the microfoam is suitable for medical treatment.The condition that allows application of the microfoam to a patient may require that the microfoam has a sclerosing effect and / or that the microfoam comprises uniform, tangential bubbles—preferably with a diameter of less than or at most 300 µm, particularly preferably less than 200 µm. The preservation process can be terminated after a certain time, which can be set or selected by the user. It is also conceivable that the user can stop the preservation process—in particular via a command using the user interface.
[0223] In a fifth aspect, the present invention relates to a microfoam obtainable by a process according to the present invention.
[0224] In a preferred embodiment, the microfoam of the present invention is a "spherical foam." The term "spherical foam" as used herein refers to a microfoam consisting of spherical bubbles filled with the gas or gas mixture used for the foaming process.
[0225] In a further preferred embodiment, the microfoam of the present invention is a tangent "spherical foam," in which the bubbles are spherical and, furthermore, all bubbles have tangent neighbors. In the context of the invention, tangent neighbors can mean that the bubbles touch each other at a single point—in particular, without any further interaction.
[0226] In a further preferred embodiment, the microfoam is a "proprietary foam." The term "proprietary foam" as used herein refers to a spherical foam in which the individual bubbles are essentially identical in size, thus forming a microfoam structure of perfect regularity.
[0227] In a sixth aspect, the present invention relates to a microfoam that is substantially nitrogen-free. Accordingly, the microfoam has a nitrogen content of less than 2%, preferably less than 1%, and particularly preferably less than 0.8%.
[0228] Microfoam according to claim 38 or 39, characterized in that the microfoam has a number of geometric disturbances which are less than 30% of the number of bubbles, preferably disturbances which are less than 10% of the number of bubbles, and particularly preferably less than 1% of the number of bubbles.
[0229] In the context of the present invention, a geometric disturbance is defined as a bubble that is 30% larger or smaller than the mean radius of the sample, preferably 20% and most preferably 10%.
[0230] With regard to geometric perturbations, the worst case scenario is when they are randomly scattered throughout the microfoam, which greatly shortens the half-life of the microfoam due to the Ostwald effect acting simultaneously at multiple locations. Preferably, the geometric perturbations should be located on one side of the sample, or in the upper or lower parts. They should most preferably be clustered in a single block along the sides, upper, or lower parts of the microfoam, and most preferably in a spherical cluster in the center of the microfoam generated within the foaming chamber.
[0231] The term "microfoam" as used herein refers to a foam with an average bubble size of less than 100 µm, preferably less than 80 µm, and more preferably less than 50 µm, measured 45 seconds after foam production. The microfoam of the invention may, for example, have an average bubble size of less than 95, 90, 85, 80, 75, 70, 65, 60, or 55 µm.
[0232] In one embodiment, the microfoam of the present invention has an average Sauter radius of less than 200 µm, preferably less than 150 µm, and more preferably less than 100 µm, measured 45 seconds after foam production. For example, the microfoam according to the invention may have an average Sauter radius of less than 190, 180, 175, 170, 165, 160, 155, 150, 145, 140, 135, 130, 125, 120, 115, 110, or less than 105 µm.
[0233] In a preferred embodiment, the microfoam has a moisture content of less than 20% by weight, and more preferably a moisture content between 8 and 12%. The microfoam according to the invention may, for example, have a moisture content of 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, or 19%.
[0234] This microfoam can be prepared according to the methods of the present invention.
[0235] In a specific example, the medical microfoam and / or liquid composition may comprise an agent solution, such as polidocanol, in a liquid, such as water or physiological saline, at a concentration of 5 mg to 20 mg in 1 ml of liquid (corresponding to a concentration of 0.05 to 2.0% by volume).
[0236] In another example, the medical microfoam and / or liquid composition may contain an agent solution, such as polidocanol, in a liquid, such as water or physiological saline, at a concentration of 2 mg to 5 mg in 1 ml of liquid (which corresponds to 0.20 - 0.50 volume weight %).
[0237] In another specific example, the medical microfoam and / or liquid composition may contain an agent solution of polidocanol in water or physiological saline at a concentration of 5 mg / ml.
[0238] In another specific example, the medical microfoam and / or liquid composition may contain an agent solution of polidocanol in water or physiological saline at a concentration of 20 mg / ml.
[0239] In some embodiments, the microfoam of the invention can be used in diagnostic or therapeutic applications.
[0240] The diagnostic use includes the use of the microfoam as an ultrasound contrast agent (USCA), whereby intravenous injection of the microfoam can cause contrast enhancement in ultrasound images. The primary application of microfoam as a USCA is in the field of echocardiography for ventricular contrast enhancement and for detecting endocardial borders. The microfoam can also be used to assess systolic function and left ventricular volume, as well as for detecting myocardial infarctions and coronary artery stenosis. The microfoam according to the invention can also be used for the detection, characterization, and image-guided treatment of focal liver lesions.Other applications include functional studies in other organs, including the kidneys, spleen, and pancreas; the assessment of diseases of the bowel, prostate, breast, and lymph nodes; and non-vascular applications such as assessing fallopian tube patency and detecting urinary reflux.
[0241] More specifically, it is the highly nonlinear response of microfoam to ultrasound that has enabled the development of a number of contrast-specific imaging protocols that have significantly expanded the diagnostic potential of ultrasound imaging. For example, harmonic imaging with microfoam—combined with advances in three-dimensional visualization techniques—has enabled microcirculation mapping to characterize tumor vascularity, including in the brain.
[0242] Microfoam can also be used for quantitative and targeted (molecular) imaging.
[0243] The ability to bind molecules to the microfoam bubbles that target specific vascular receptor sites opens up further possibilities for tissue-specific imaging and disease states such as inflammation, angiogenesis, and atherosclerosis.
[0244] Heavy gases are preferred for use as USCAs, as they are less water-soluble and therefore result in a microfoam with a longer microfoam lifespan. Examples of heavy gases include sulfur hexafluoride, octafluoropropane, octafluorobutane, octafluoropentane, and octafluorohexane. Specifically, there are currently four clinically available microfoam-based USCAs, summarized in the table below: name capsule gas Approved indication Sonovue® / Limason® Phospholipid Sulfur hexafluoride - Left ventricular contrast - Definition of the endocardial border - Breast - Liver - Vascular system - Urinary tract Definity® / Luminity® Phospholipid Octafluoropropane (Perflutren) - Left ventricular contrast - Definition of the endocardial border - Liver - Kidney - Vascular system Optison® albumin Octafluoropropane (Perflutren) - Left ventricular contrast - Definition of the endocardial border Sonazoid® Phospholipid Octafluoropropane - Breast (Perflutren) - Liver - Myocardial perfusion
[0245] In an alternative embodiment, the microfoam of the invention can be used for therapeutic applications. For example, in the delivery of drugs and genes, the microfoam bubbles can be used as targeted vehicles that are loaded with the desired therapeutic agent, tracked to the target site using low-intensity ultrasound, and then disrupted with a high-intensity burst after attachment to release the material locally, thus avoiding systemic administration of, for example, toxic chemotherapy.
[0246] In gene delivery, the microfoam bubbles can be used as targeted vehicles loaded with the required genetic material, which can be single- or double-stranded DNA or RNA, or a gene vector such as a plasmid, a viral vector, a cosmid, or an artificial chromosome.
[0247] Sonodynamic therapy (SDT) is a newer concept and involves the combination of ultrasound and a sonosensitizing drug (also referred to herein as a "sonosensitizer"). Similar to photodynamic therapy (PDT), activation of the sonosensitizer by acoustic energy leads to the generation of reactive oxygen species (ROS), such as singlet oxygen, at the target site of interest. Such species are cytotoxic, thus killing target cells or at least reducing their proliferative potential. Many known photosensitizing agents can be activated by acoustic energy and are thus suitable for use in SDT. Because ultrasound readily propagates through several centimeters of tissue, SDT provides a means to treat tumors located deep within tissue.Like light, ultrasound energy can be focused on a tumor mass to activate the sonosensitizer, thereby limiting its effect to the target site.
[0248] SDT offers several significant advantages over PDT: Ultrasound is widely recognized as a cost-effective and safe clinical imaging modality and, unlike light, can be sharply focused, with its penetration depth into soft tissue reaching up to several tens of centimeters, depending on the ultrasound frequency used.
[0249] Accordingly, the gas-filled microbubbles of the microfoam of the present invention can be conjugated with sonosensitizers to obtain a microbubble-sonosensitizer "complex" for use in SDT. These complexes allow effective delivery of the active sonosensitizer in a site-specific manner through controlled disruption of the bubble using ultrasound. Subsequent or simultaneous sonoactivation of the targeted sonosensitizer leads to cell destruction at the target site and regression of the tumor tissue. The use of a microbubble also leads to a reduction in toxic side effects, as the sonosensitizer is shielded from potential light activation before reaching the desired target site.
[0250] The movement of microfoam bubbles is known to increase the permeability of both individual cell membranes and the endothelium, including a temporary opening of the blood-brain barrier. Accordingly, the microfoam bubbles of the invention can not only function as a delivery vehicle, but they also actively promote the uptake of therapeutic material.
[0251] In the case of a therapeutic microfoam, targeting can also be achieved by filling the microfoam bubbles with an acoustically active gas that allows radiation-induced movement of the microfoam bubbles towards the target site.
[0252] In an alternative embodiment, the microfoam of the invention can be used for non-medical applications. The microfoam of the present invention can also be used for cleaning purposes, such as cleaning semiconductor wafers (see EP 2 202 782 B1).
[0253] In a seventh aspect, the present invention relates to a computer program comprising instructions for performing steps of the method of the invention which, when the program is executed by a computer, cause the computer to perform the following steps: a. Providing a user interface for controlling a foaming process for generating a microfoam, in particular by configuring at least one parameter of the foaming process and / or by initiating the foaming process, wherein the at least one parameter is selected from the following: a gas concentration, a mixing ratio of the gas mixture, a selection of the liquid composition, a mixing ratio of the agent solution, a concentration of the agent solution in the microfoam, a language and a foaming profile (204), b. Providing at least one graphical element (201) as part of the user interface (200) for selecting or configuring the at least one parameter, c. Providing at least one graphical control element (202) for instructing the computer program, in particular a graphical control element (202) for aborting the computer program and / or a graphical control element (202) for continuing the computer program and / or a graphical control element (202) for going back one step in the computer program, d. Providing at least one graphical section (203) as part of the user interface (200) showing at least one instructive image (205) and / or at least one informative image (206) for instructing or informing a user.
[0254] The user interface can be provided at least partially as a graphical user interface, in particular on a graphical screen. The graphical screen can be provided as a touch screen. The at least one graphical element and / or the at least one graphical control element can be selected via the graphical screen by directly touching the graphical screen or via an interface, for example via a mouse or a keyboard or at least one mechanical button. The instructing image can show graphical instructions, for example the movement the user has to perform, how to prepare the foaming process or how and / or where to inject a foaming agent and / or how to clean the device.The informative image may include status information of the foaming process or information about how one or more parameters for the foaming process were selected, or information about a current state of at least one parameter during the foaming process. The user interface may be provided as at least two separate views, each view comprising at least one graphical element and / or at least one graphical control element and / or at least one graphical section comprising at least one instructive image and / or at least one informative image. The elements may vary in size and / or position, and the graphical section may also vary with regard to the content provided within each view.
[0255] It may be conceivable that the computer program further includes instructions that, when executed by a computer, cause the computer to log important events and status information in a log file. The log may include at least one of the following information: major activity at the user interface, changes to the device configuration, details of the agent and consumable quantities used for foaming, identification of the cartridges used, the number of foaming cycles, and the total cartridge lifespan, identification of hardware and software versions, results of power-on self-tests, and / or malfunctions during operation.
[0256] It is further conceivable that the computer program further comprises the following step: - Providing at least one default value for the at least one parameter.
[0257] A “default value” in this context can be understood as a value that is chosen in advance and that is used for the foaming process or for the user interface in case the user either wants to keep this default value or forgets to change it.
[0258] In some embodiments, the foaming profile (204) of the computer program comprises at least one of the following parameters: - Profile name and description, - names of the foaming agent, diluent and gases, - List of compatible cartridges, - available selection of agent input concentration, - valid range of the agent input concentration, - Volume of agent to be injected into the cartridge, - available selection of agent concentration in the foam, - available selection of gas ratios, - detailed instructions for preparing the microfoam, - Limit of freshness of the microfoam after production, - Expiry date / use period of the cartridge. - Foaming parameters, such as speed or ramp definitions. Definitions:
[0259] In the context of the invention, indefinite and definite articles or numerical indications, for example, "one," "two," etc., are always to be understood as "at least" indications, unless expressly stated otherwise. Furthermore, numerical indications, as well as indications of process parameters and / or device parameters, are to be understood in the technical sense, i.e., with the usual tolerances. Furthermore, the explicit indication of "at least" or the like must not be taken to imply that the sole use of the article or numerical indication, i.e., without the indication of "at least" or the like, implies a limitation, for example, in the sense of "exactly one."
[0260] The phrase “in some embodiments” may be used interchangeably with “in one or more embodiments.”
[0261] The gas or gas mixture within the meaning of this text can also be an "acoustically active gas" or a mixture thereof. An "acoustically active gas" within the meaning of this text means any gas (such as perfluorobutane) that can be enclosed in a bubble of the microfoam and vibrates in the presence of an acoustically generated radiation force, thereby causing movement in the direction of the force. Suitable gases are inert and biocompatible. These include, for example, air, noble gases such as helium, rubidium, hyperpolarized xenon, hyperpolarized argon, hyperpolarized helium, neon, argon, xenon, carbon dioxide, nitrogen, fluorine, oxygen, sulfur-containing gases such as sulfur hexafluoride and sulfur tetrafluoride, as well as fluorinated gases. The resulting microfoam is particularly suitable for diagnostic and therapeutic applications.
[0262] Within the scope of the invention, the term "fluid line" describes a line for transporting a fluid from one end, for example, one part of the device, to another, preferably without fluid loss, particularly preferably by providing a watertight and / or gas-tight environment or a watertight and / or gas-tight path. The fluid line can be a hose, a channel, or a pipe. Preferably, the fluid line is a flexible hose.
[0263] The term "liquid composition" may refer to a composition in liquid form. The liquid composition may contain at least one foaming agent and may also refer to a liquid sclerotherapy composition. Using a foaming process, the microfoam may be produced from the liquid sclerotherapy composition and may therefore also be referred to as a foamed sclerotherapy composition. For example, using the foaming process, the liquid composition is foamed by the rotation of the foaming element. The liquid composition may therefore form a component for obtaining the foamed sclerotherapy composition. The liquid compositions according to the examples of the present disclosure comprise a foaming agent and also a suitable aqueous diluent as a vehicle that can be injected into the affected veins without toxicity.In some examples, a liquid may be selected from sterile water (especially distilled water) and physiological saline. This liquid, which serves as the vehicle, may be referred to as the diluent within the scope of the present invention.
[0264] Further advantages, features, and details of the invention will become apparent from the following description, in which embodiments of the invention are described in detail with reference to the drawings. In this context, the features mentioned in the claims and in the description may be essential to the invention individually or in any combination. The following is shown in the figures: Fig. 1 Schematic cross-sectional drawing showing an embodiment of the cartridge of the invention, Fig.2 Cross-sectional drawing showing an embodiment of the cartridge of the invention, the partial view showing the reaction chamber and the waste chamber, Fig. 3 Cross-sectional drawing showing an embodiment of the reaction chamber of the invention shown as contained within the cartridge of the invention, Fig. 4 Schematic drawing showing an example of a foaming element according to the invention and a restriction arrangement according to the invention with a projection (A) or with an end stop plate (B), Fig. 5 Drawing showing an embodiment of the cartridge of the invention, viewed obliquely from above, after the top cover has been removed and the fluid lines have been removed, Fig. 6 Drawing showing an embodiment of the cartridge of the invention, viewed obliquely from above after the upper cover has been removed, Fig.7 Drawing showing an embodiment of the cartridge of the invention, viewed obliquely from above after the complete cartridge housing has been removed, Fig. 8 drawing showing an embodiment of the cartridge of the invention in rear view and side view after the syringe 115 has been removed, Fig. 9 Drawing showing an embodiment of the cartridge holder of the automated system of the invention in front view (A) and rear view (B), both viewed at an angle from above, without the cartridge inserted, Fig. 10 Schematic drawing showing the flow path for the aqueous diluent within the automated system 1 of the invention containing the cartridge 100, Fig. 11 Schematic drawing showing the flow path for the gas within the cartridge of the invention 100, Fig.12 Flowchart illustrating the process step of microfoam generation using an automated system 1 and a cartridge 100 according to an embodiment of the present invention, Fig. 13 Schematic drawing of cross sections of a cartridge according to an embodiment of the invention, showing the cleaning steps for the foaming chamber, Fig. 14 Schematic drawing of cross sections of a cartridge according to an embodiment of the invention, showing steps that prepare the foaming chamber for the foaming process, Fig. 15 Schematic drawing of a cross-section of a cartridge according to an embodiment of the invention, showing the step of removing microfoam from the foaming chamber, Fig. 16 Conceptual view of a user interface according to the invention, Fig.17 Conceptual view of a user interface according to the invention on which a foaming profile can be selected, Fig. 18 The bubble distribution for a microfoam according to the invention. The measurements were recorded 45 seconds (A) and 115 seconds (B) after foaming the same microfoam. Fig. 19 (A) Bubble distribution for PEM, Tessari and DSS samples as shown in Fig. by Roberts et al, 2020 (Biorheology; 57 (2-4): 77-85); (B) Table with measured values taken from the data for PEM, Tessari and DSS (see Tables 1 to 3 of Roberts et al. 2000), compared with measurements taken from the data of the microfoam of the invention, as shown in Fig. The table lists the mean bubble size and the mean Sauter radius, both given in µm. Fig.20 Schematic drawing of three different devices for generating microfoam: (a) the double syringe system (DSS). In the DSS, the sclerotherapy fluid and gas are passed between two syringes connected by a simple straight connector. (b) The Tessari procedure is similar to the DSS procedure, except that the straight connector is replaced by a three-way valve. (c) Polidocanol Endovenous Microfoam (PEM) is a product generated by a proprietary device called Varithena® (Injectable Polidocanol Foam 1%; Provensis Ltd., a BTG International company), which produces pharmaceutical-grade, low-nitrogen foam (O2 to CO2 ratio = 65:35).
[0265] Fig.1 shows a cross-section through the cartridge 100 with the housing 101. A syringe 115 is arranged within the cartridge as a foaming agent reservoir, which is connected to the foaming agent reservoir port 125 and sends the foaming agent through the fluid line 126 to the foaming chamber of the reaction container 160. An external gas supply system 114 is connected to the gas supply port 134 of the cartridge via a gas inlet port 124 and supplies the gas through the fluid line 121 to the foaming chamber of the reaction vessel 160. An external diluent supply system 134 is connected to the diluent supply port 133 of the cartridge via a diluent inlet port 123 and supplies the diluent through the fluid line 120 to the foaming chamber of the reaction vessel 160, which has a rotatable foaming element 130 located at the bottom of the foaming chamber.Thorough mixing of the gas and the foaming agent diluted with the diluent creates a microfoam 10, which is transported through fluid line 116 to foam removal port 170, where it can be removed by the user. The waste material 166 from the foaming process can be removed by transporting it through fluid line 162 to a waste chamber 161.
[0266] Fig.Figure 2 shows a cross-section of an embodiment of the reaction vessel of the invention 160 as contained in the cartridge 100 of the invention with the housing 101, along with a cross-section of the waste chamber 161, shown without the top lid. The reaction vessel 160 defines a cylindrical foaming chamber with a dome-shaped upper part 171 for a more homogeneous gas distribution, with the gas being supplied through the first inlet channel 172. At the bottom of the foaming chamber, a rotating foaming element 130 is arranged, which is equipped with magnets 132 for magnetically driving by an externally arranged magnetic stirrer 135 (not shown). The rotatable foaming element 130 is formed as a disc with a central elevation.The rotatable foaming element 130 has radially arranged, tooth-like projections as mixing elements 131, which are bent upward to provide a defined gap between the teeth and the surrounding reaction vessel. The foaming chamber has a deflection element for forced deflection, which generates a downward movement of the fluid toward the rotating foaming element in the lower part during the foaming process. In this specific embodiment, the deflection element is designed as a deflection body 141.The deflection body 141 is located above the foaming element 130 and is formed as a circular ring segment with a trapezoidal basic structure, having a side 142 beveled toward the bottom of the foaming chamber and a lower horizontal side located above the rotatable foaming element to form a gap between the deflection body and the upper edge of the rotatable foaming element. The circular ring segment is attached to the cylindrical wall of the foaming chamber and has a radial annular thickness that substantially covers the mixing elements 131 of the rotatable disc 130. The foaming chamber 160 is connected to the waste inlet 164 of the waste container 161 via the second outlet channel 159 and the valve 163.
[0267] Fig.Figure 3 shows a cross-section of an embodiment of the reaction vessel of the invention 160, as contained in the cartridge 100 of the invention with the housing 101. The reaction vessel 160 defines a cylindrical foaming chamber with a dome-shaped upper part 171 for a more homogeneous gas distribution, with the gas being supplied through the first inlet channel 172 and the aqueous diluent being supplied through the second inlet channel 173. At the bottom of the foaming chamber, a rotating foaming element 130 with a central axis is arranged as a positioning element 140 and is equipped with magnets 132 to be magnetically driven by an externally arranged magnetic stirrer 135 (not shown). The rotatable foaming element 130 is designed as a disc with mixing elements 131, which are radially arranged, tooth-like projections that are bent upwards to provide a defined gap between the teeth and the surrounding reaction vessel.The foaming chamber has a deflection element 141 for forced deflection, which during the foaming process generates a downward movement of the fluid toward the rotating foaming element in the lower part. In this specific embodiment, the deflection element is designed as a deflection body 141. The deflection body 141 is located above the foaming element 130 and is formed as a circular ring segment with a trapezoidal basic structure, which has a side 142 beveled towards the bottom of the foaming chamber and a lower horizontal side located above the rotatable foaming element to form a gap between the deflection body and the upper edge of the rotatable foaming element. The circular ring segment is attached to the cylindrical wall of the foaming chamber and has a radial ring thickness that substantially covers the mixing elements 131 of the rotatable disk 130.The illustrated orientation of the beveled side operates with a foaming element that rotates clockwise when viewed from above. The foaming chamber 160 further includes a first outlet channel 174 for removing the microfoam from the foaming chamber 160. The first outlet channel 174 is located at the bottom of the foaming chamber below the deflection body 141.
[0268] Fig. 4 shows two possible embodiments of the foaming element 130 according to the invention and the corresponding restriction arrangement 150. In Fig. 4 A, the limiting arrangement 150 comprises a projection 151 for limiting the translational movement of the foaming element 130. The foaming element 130 has extensions 131 towards its outer ends. In Fig. 4 B, the restriction assembly 150 further includes an end stop plate 152 to further restrict the translational movement of the foaming element 130.
[0269] Fig.Figure 5 shows the cartridge 100 of the invention, viewed obliquely from above, after the top cover has been removed to allow a view into the housing 101. The fluid lines with the associated sterile filters and Luer connectors have also been removed to reveal the basic elements of the cartridge. The cartridge housing has a central opening 103 for the syringe plunger 117 (not shown) of the syringe 115 (not shown), which functions as a foaming agent reservoir. The housing further includes two fastening elements 102 that enable the cartridge 100 to be attached to the cartridge holder 99 (not shown).At the bottom of the housing are three receptacles 105, which engage with respective guide elements 106 (not shown) of the cartridge holder 99 to lock the cartridge in a precisely defined position, ensuring the secure transport of the gas and diluent from the automated system 1 (not shown) to the cartridge 100. The housing includes the diluent supply port 133 for supplying the aqueous diluent from the automated system to the cartridge, which connects to the diluent introduction port 123 (not shown) of the cartridge holder 99. The housing further includes the gas supply port 134 for supplying the gas or gas mixture from the automated system 1 to the cartridge 100, which connects to the gas introduction port 124 (not shown) of the cartridge holder 99.The cartridge further comprises the reaction vessel 160 with its first inlet channel for gas supply 172 at the top, the second inlet channel for supplying the aqueous diluent 173, and the third inlet channel for supplying the foaming agent, which is located in the lower part of the foaming chamber and controlled by the valve 136 below. A large waste container 161 is arranged next to the reaction chamber 160, which is shown here without the upper part of the walls and without the top lid in order to show the internal structures, such as the inlet of the waste container 163, which is formed as an opening in a vertical hollow tube, with the flow of waste material controlled by an underlying valve 163 (not shown).
[0270] Fig.Figure 6 shows the cartridge 100 of the invention, viewed obliquely from above, after the top cover has been removed to allow a view into the housing 101. The Fig. described elements are also present here. In addition, Fig.6 shows the fluid network of the cartridge with associated elements, as follows: After the aqueous diluent enters the cartridge through the diluent supply port 133 (not shown), it is passed through the sterile filter 129, which is connected to the fluid line 120 for diluent transport via a Luer connector 122. The fluid line transports the diluent to the second inlet channel 173 (not shown), which is connected to the line via another Luer connector 122. The gas or gas mixture entering the cartridge via the gas supply port 134 flows via the fluid line 121m, the Luer connector 122, and the sterile filter 129 to the first inlet channel of the foaming chamber of the reaction vessel 160. The microfoam generated in the foaming chamber of the reaction vessel 160 is removed from the cartridge via the foam removal port 170.At the top of the waste container 163 is a gas outlet 165 equipped with a sterile filter 129 to filter the gas leaving the waste container and entering the interior of the cartridge. The cartridge further includes the syringe 115 with its plunger 117, which acts as a foaming agent reservoir and is connected to the foaming agent reservoir port 125, which is connected via the T-piece 128 (not visible from this perspective) to the third inlet channel of the foaming chamber 175 (not shown) and the foaming agent supply port 127. The piston 117 penetrates the opening 103 of the cartridge housing 101 and protrudes from the cartridge to penetrate the respective opening 104 (not shown) in the cartridge holder 99 (not shown) to be pushed by a respective punch of the automated system 1 (not shown).
[0271] Fig.Figure 7 shows the cartridge 100 of the invention, viewed in a perspective front view after the complete housing 101 of the cartridge has been removed to show the internal elements of the cartridge. Fig. The elements described are also shown here, and the respective descriptions apply here as well. The perspective taken here also shows the diluent supply port 133, which is connected to the sterile filter 129, and the T-piece 128 for distributing the foaming agent.
[0272] Fig.Figure 8 shows an embodiment of the cartridge of the invention in rear and side views after the syringe 115 has been removed. The cartridge housing has a central opening 103 for the syringe plunger 117 (not shown) of the syringe 115 (not shown), which functions as a foaming agent reservoir. The housing further includes two fastening elements 102 that enable the cartridge 100 to be attached to the cartridge holder 99 (not shown). Furthermore, the cartridge includes the engaging lugs 107 for engaging the respective engaging recesses 108 (not shown) arranged in the cartridge holder 99 (not shown). The gas supply port 134 is located on the rear side.
[0273] Fig.Figure 9 shows an embodiment of the cartridge holder 99 of the automated system 1 of the invention, viewed in front view (A) and rear view (B), both viewed at an angle from above, without the cartridge inserted. The bottom plate of the cartridge holder includes three plugs 106 that secure the precise position of the cartridge by engaging the respective three receptacles 105 arranged in the bottom of the cartridge 100 (both not shown here). The bottom plate of the cartridge holder further contains the diluent supply port 123 for supplying the gas or gas mixture from the automated system 1 to the cartridge 100.
[0274] Also located within the base plate is a plunger 137 for controlling valve 136, which is located on the outer bottom surface of the cartridge and controls the flow of foaming agent. Also located within the base plate is a plunger 167 for controlling valve 163, which is located on the outer bottom surface of the cartridge and controls the flow of waste material from the foaming chamber to the waste container. The cartridge holder further includes an opening 104 for inserting syringe plunger 117 (not shown here). Located in the lower part of the walls of holder 99 are three engagement recesses 108, into which the respective engagement lugs 107 of cartridge 100 (both not shown here) engage.
[0275] Fig. Figure 10 shows the flow path for the aqueous diluent within the automated system 1 of the invention containing the cartridge 100, Fig.Figure 10A shows the main part of the automated system 1 in front view, with the front cover removed to show the diluent delivery system 113. A saline infusion bag 180 is installed within the automated system. A silicone tube is connected to the saline bag, from which the diluent is transported to the rotating peristaltic pump (arrow a), from there to the cartridge holder (arrow b), and further to the cartridge 100 inserted into the automated system 1. As shown in (B), the diluent enters the cartridge via the diluent delivery port 133 (arrow c). As shown in (C), the diluent is transported into the interior of the cartridge toward the rear of the cartridge (arrows d and e), where a capacitive sensor in the automated system (not shown here) detects the presence of liquid in the fluid line.The measuring area is represented by the dotted ellipse 176. The diluent is finally transported to the second inlet channel 173 (arrow f), where it enters the foaming chamber of the reaction vessel.
[0276] Fig. 11 shows the flow path for the aqueous diluent within the cartridge 100. Fig.Figure 11A shows the cartridge from a rear view, with the gas or gas mixture coming from the automated system 1 (not shown here) entering the cartridge via the gas supply port 134 (arrow h). The gas is then transported via the fluid line to the first inlet channel 172 (arrow j), where it enters the foaming chamber of the reaction vessel. After completion of the foaming process, including foam removal, the residual waste in the foaming chamber can be transported to the waste container by another gas flow, with a mixture of gas and waste entering the waste container through the waste inlet 164 (arrow k).
[0277] Fig.12 shows a flowchart illustrating the process step of microfoam generation using an automated system 1 and a cartridge 100 according to an embodiment of the present invention. Optional steps are represented by dashed rectangles. In step 1, the saline solution tube is prefilled, and saline solution and gas are pumped into the foaming chamber of the reaction vessel. In an optional step 2, the foaming chamber can be cleaned by washing the foaming chamber with a saline solution and / or by purging with gas. Thereafter, according to step 3, defined quantities of saline solution and foaming agent are supplied to the foaming chamber together with a gas or gas mixture with a defined gas ratio. In the subsequent step 4, which defines the initial foaming process, the foaming element is set in rotation and reaches (preferably gradually) the maximum speed.In the main foaming process according to step 5, the maximum speed of the foaming element is maintained for a defined period of time to generate a microfoam with the target parameters. In step 6, the speed is reduced to allow foam removal, which is assisted by creating a slight overpressure within the foaming chamber, allowing the user to remove the microfoam from the foaming chamber in step 7. Optionally, the user can remove additional quantities of microfoam according to step 8. In particular, the automated system allows repeated execution of the microfoam generation process, so that after steps 7 or 8, another foam generation process can be initiated by starting again with step 1.
[0278] Fig.Figure 13 shows cross-sections of a cartridge according to an embodiment of the invention, illustrating cleaning steps for the foaming chamber. As shown in (A), the foaming chamber is cleaned by washing with saline solution entering the second inlet channel 173 and purging with a gas / gas mixture entering the first inlet channel 17. The gas or gas mixture intended for the foaming process should also be used for the cleaning step to equilibrate the foaming chamber with the final gas or gas mixture.As shown in (B), the gas and saline solution, together with possible residues from a previous foaming process, are removed from the foaming chamber by further introducing the gas or gas mixture into the foaming chamber while the waste transport controlling valve 163 is opened (m), so that the residues from the foaming chamber (arrow 1) are transported through the second outlet channel 159 (arrow m) to enter the waste container 161 via the waste inlet (arrow n).
[0279] Fig.14 shows cross-sections of a cartridge according to an embodiment of the invention, illustrating steps for preparing the foaming chamber for the foaming process. As shown in (A), the defined gas or gas mixture is introduced into the foaming chamber via the first inlet channel 172, while the valve 163a is opened to allow the gas or gas mixture to leave the foaming chamber via the second outlet channel to enter the waste container. As a result, the foaming chamber is equilibrated with the defined gas or gas mixture to be used to produce the microfoam. In the next step, the valve 163b is closed as shown in B, and a defined amount of saline solution is introduced into the foaming chamber via the second inlet channel 173, and a defined amount of foaming agent is also introduced into the foaming chamber via the third inlet channel 175.Temporarily opening a vent valve, which is part of the gas distribution system of automated system 1 (not shown here), before introducing the diluent and foaming agent prevents overpressure within the foaming chamber during the supply of the diluent and foaming agent. As a result, the foaming chamber is supplied with all the necessary components of the foaming process—the foaming agent, the aqueous diluent, and also the gas or gas mixture.
[0280] Fig.15 shows a schematic drawing of a cross-section of a cartridge according to an embodiment of the invention, illustrating the step of removing microfoam from the foaming chamber. By opening the valve 136 and introducing the defined gas or gas mixture into the foaming chamber via the first inlet channel 172 to generate a slight "foam removal overpressure" within the foaming chamber, the microfoam can be removed through the first outlet channel—preferably by inserting a syringe through the valve of the foam removal port and sucking out the microfoam. A slight "foam removal overpressure" within the meaning of the present text means an overpressure of 20 mbar or less, and preferably of 10 mbar or less.
[0281] Fig.Figure 16 shows a conceptual view of an embodiment of a user interface 200 according to the invention. It should be noted that this embodiment merely represents a graphical user interface, to which a user interface according to the invention need not be limited, since it may further comprise elements such as a screen, in particular a touch screen, mechanical keys, or an interface such as a keyboard or mouse. The user interface 200 in Fig.16 includes a plurality of graphical control elements 202 that can provide functions such as aborting a computer program and / or continuing a computer program and / or going back one step in a computer program. The user interface 200 further includes a plurality of graphical elements 201 that can allow a selection of at least one parameter for the foaming process, such as a concentration of an agent solution, or at least one parameter related to the user interface 200, such as a language. The user interface 200 also includes two graphical sections 203. In one of the graphical sections 203, a plurality of informative images 206 are provided, which can show parameters related to the foaming process selected by the user or which describe a current state of the foaming process. In the other graphical section 203, an instructive image 205 is provided.The instructional image 205 can show a user how to install the cartridge, how and / or where to provide an agent solution, how to clean the cartridge, or how and / or where to remove the microfoam 10 according to the invention after the foaming process. The graphical control elements 202 and the graphical elements 201 can be controlled or actuated via a touchscreen or by clicking with a mouse or by means of a keyboard or mechanical keys.
[0282] Fig. Figure 17 shows a further conceptual view of an embodiment of a user interface 200 according to the invention. As mentioned in the previous section, the user interface according to the invention does not need to be a graphical user interface such as that in Fig. 16 and Fig. 17. The user interface 200 in Fig.17 comprises a graphical section 203 containing several informative images 206. The user interface 200 further comprises a graphical element 201 and two graphical control elements 202. The above-mentioned graphical element 201 and the two graphical control elements 202 can provide the same functionalities as described with respect to Fig. 16. The user interface 200 in Fig. 17 also includes multiple foaming profiles 204. This may indicate that a user can select a specific foaming profile 204 from the provided foaming profiles, which may be done according to specific application requirements, particularly medical requirements. The foaming profile selection may be made by swiping and / or tapping on a touchscreen, by clicking with a mouse, or using a keyboard or mechanical keys.
[0283] Fig.Figure 18 shows the bubble distribution for a microfoam according to the invention. The measurements were recorded 45 seconds (A) and 115 seconds (B) after foam production for the same microfoam. The microfoam was produced as follows: The microfoam was filled with a cartridge as described in the Fig.shown, generated at room temperature. After purging the foaming chamber with a gas mixture of 80% oxygen and 20% carbon dioxide, 2 ml of an aqueous 2% polidocanol solution and 18 ml of an isotonic 0.8% sodium chloride solution were injected into the cartridge. The cartridge rotor is then driven by an external magnetic stirrer according to the following reaction settings: 1. Pre-foaming: 10-second ramp from 0 to 2,000 rpm and hold at 2,000 rpm for 20 seconds; 2. Foaming: 10-second ramp from 2,000 rpm to 4,000 rpm and hold at 4,000 rpm for 40 seconds; 3. Withdrawal phase: Maintaining the speed at 4,000 rpm for up to several minutes. The cartridge's foaming chamber includes a pressure equalization device to compensate for pressure fluctuations within the foaming chamber. The process generates approximately 20 ml of microfoam with a moisture content of 15.9 ± 2.01 wt%.The freshly generated microfoam is then removed from the foam dispensing port of the cartridge using a syringe.
[0284] Fig. Figure 19(A) shows the bubble distribution for PEM, Tessari and DSS (double syringe system) samples as shown in Fig. by Roberts et al, 2020 (Biorheology; 57 (2-4): 77-85).
[0285] A 1% aqueous buffered polidocanol solution was used to prepare PCFs for all three microfoams. The mean bubble size, expressed in µm, is an average value for the entire foam, i.e., the sum of the bubble radii divided by the number of bubbles. Instead of this unweighted mean, the mean Sauter radius is known to be the most suitable average bubble size for predicting the rheological properties of foams. The mean Sauter radius approximates the average bubble size based on the volume-to-surface area ratio. In particular, the mean Sauter radius is sensitive to the presence of large bubbles, as a long tail in the bubble size distribution is known to have a significant impact on foam behavior. For this reason, a narrow bubble size distribution is more suitable for sclerotherapy.The three microfoams were generated as follows: The DSS foam was prepared by moving 1 ml of polidocanol from a 5-ml syringe (Discardit™ II, Becton Dickinson, Erembodegem, Belgium) into and out of a 10-ml syringe containing 7 ml of gas ten times. The syringes were connected via a straight connector (equivalent to a female-to-female Luer Lock connector, QOSINA, Edgewood, New York, USA). In the Tessari procedure, the straight connector is replaced by a 3-way valve (BD Connecta™ 3-Way Stopcocks, Becton Dickinson, Erembodegem, Belgium). A further modification consists of positioning the valve stopcock at a 30° angle to increase the shear effect as the foam passes between the syringes, which was used in the present study. As with the DSS process, 5 and 10 ml syringes were used to prepare the foam. PEM is a combination medication product manufactured by Provensis Ltd.(a BTG International Group company, London, United Kingdom). It consists of a proprietary 65:35 gas mixture of O2 and CO2 with extremely low nitrogen content (<0.8%) and a 1% polidocanol solution (without added stabilizers), contained in a pressurized canister, which combines to form a uniform microfoam upon exiting the canister. Sterile canisters of the product were used according to the Instructions For Use (IFU) to generate 5 ml of microfoam for experimentation. The microfoam was drawn from the canister via a Microfoam Transfer Unit (MTU) into a 10 ml Norm-Ject syringe (Henke-Sass Wolf, Tuttlingen, Germany).
[0286] As shown in the table of Fig.As shown in Figure 19 (B), the device according to the invention produces an excellent microfoam exhibiting a drastic reduction in the mean bubble size and the mean Sauter radius. This is all the more remarkable because the microfoam of the invention was produced with a reduced polidocanol concentration (0.2% instead of 1%), since a reduction in the foaming agent concentration makes it difficult to produce a microfoam with sufficient stability.
[0287] Fig.Figure 20 shows three devices for producing microfoam. In the DSS method, syringes are connected by a Combidyn® adapter (a), while in the Tessari method, they are connected by a three-way valve (b). In both techniques, the foam was produced by moving the polidocanol solution (liquid phase) from one syringe into and out of the other syringe, which originally contained the gas or gas mixture (gaseous phase), ten times. Foam was produced at room temperature (20°C to 22°C). The proprietary canister system for generating PEM (Varithena®) is shown in (c).
[0288] The preceding explanation of the embodiments describes the present invention exclusively by way of example. Of course, individual features of the embodiments can be freely combined with one another, provided this is technically feasible, without departing from the scope of the present invention. List of reference symbols 1 Automated system 10 microfoam 99 cartridge holders 100 cartridges 101 cartridge housings 102 Fastening element on the cartridge housing 103 Opening in the cartridge housing for the syringe plunger 104 Opening in the cartridge holder for the syringe plunger 105 Receptacle in the cartridge housing for engagement by guide elements 106 Plug in the cartridge holder as a guide element 107 Lug for engaging the cartridge holder 108 Recess for engagement through the engagement nose 107 of the cartridge 113 Diluent supply system 114 Gas supply system 115 Syringe as foaming agent reservoir 116 Fluid line for microfoam transport 117 Syringe plunger 120 Fluid line for diluent transport 121 Fluid line for gas transport 122 Luer-Lock connectors 123 Diluent introduction port 124 Gas inlet port 125 Foaming agent reservoir port 126 Fluid line for foaming agent 127 Foaming agent feed port 128 T-piece in the fluid line of the foaming agent 129 Sterile Filter 130 Rotatable foaming element 131 mixing elements 132 Magnet 133 Diluent supply port 134 Gas supply port 135 Magnetic stirring device 136 Valve for controlling the supply of foaming agent 137 Pressure piston for controlling the valve 136 140 Positioning element 141 Deflection body 142 Beveled side of the deflection body 150 Restriction element 151 lead 152 End stop plate 159 Second outlet channel of the foaming chamber for removing waste 160 reaction vessels with foaming chamber 161 Waste container defining a waste chamber 162 Fluid line for waste transport 163 Valve for controlling waste transport 163a Valve for controlling waste transport is open 163b Valve for controlling waste transport is closed 164 Waste container inlet 165 Waste container gas outlet 166 Waste 167 Pressure piston for controlling valve 163 for waste transport 170 Foam extraction port 171 Dome-shaped upper part of the foaming chamber 172 First inlet channel of the foaming chamber for the gas supply 173 Second inlet channel of the foaming chamber for the diluent supply 174 First outlet channel of the foaming chamber for removing microfoam 175 Third inlet channel of the foaming chamber for the foaming agent supply 176 Area for controlling the diluent flow in the fluid line 180 saline infusion bags 185 Peristaltic pump 200 User Interface 201 Graphic element 202 Graphic control element 203 Graphic Section 204 foam profile 205 Instructive Image 206 Informative Image QUOTES CONTAINED IN THE DESCRIPTION
[0000] This list of documents submitted by the applicant was generated automatically and is included solely for the convenience of the reader. This list is not part of the German patent or utility model application. The DPMA assumes no liability for any errors or omissions. Cited patent literature
[0000] US2017 / 144115
[0004] WO2017 / 085209
[0005] WO2020 / 0389A1
[0006] EP 2 202 782 B1
[0252] Cited non-patent literature
[0000] Roberts et al, 2020 (Biorheology; 57 (2-4): 77-85
[0284]
Claims
[1] Reaction vessel for producing a microfoam, comprising a vessel body defining a foaming chamber and containing: a rotatable foaming element arranged in the foaming chamber for carrying out a foaming process to produce the microfoam from a liquid foaming composition, b. a positioning element at the bottom of the foaming chamber, which holds the foaming element in such a way that it is rotatable about a predefined axis during the foaming process, c. a first outlet channel arranged adjacent to or at the lower part of the foaming chamber and in fluid communication with the foaming chamber for withdrawing the microfoam from the foaming chamber. [2] Reaction vessel according to claim 1, characterized by that the container body defining the foaming chamber further has one or more of the following properties and preferably all of the following properties: a first inlet channel in fluid communication with the foaming chamber for supplying a gas or gas mixture to the foaming chamber, the first inlet channel preferably being arranged at the upper part of the foaming chamber, b1. a second inlet channel in fluid communication with the foaming chamber for supplying a mixture comprising a foaming agent and an aqueous diluent to the foaming chamber, the second inlet channel preferably being arranged adjacent to or at the lower part of the foaming chamber, or b2. a second inlet channel in fluid communication with the foaming chamber for supplying an aqueous diluent to the foaming chamber, the second inlet channel preferably being arranged at the upper part of the foaming chamber and being provided together with a third inlet channel in fluid communication with the foaming chamber for supplying a foaming agent to the foaming chamber, the third inlet channel preferably being arranged adjacent to or at the lower part of the foaming chamber. [3] Reaction vessel according to claim 1 or 2, characterized by that the container body defining the foaming chamber further comprises a second outlet channel in fluid communication with the foaming chamber for removing waste material from the foaming chamber, wherein the second outlet channel is preferably arranged adjacent to or at the lower part of the foaming chamber. [4] Reaction vessel according to one of the preceding claims, characterized bythat the container body defining the foaming chamber further comprises a deflection element for forced deflection, which creates a downward fluid movement towards the rotating foaming element at the lower part during the foaming process. [5] Reaction vessel according to one of the preceding claims, characterized by that the container body is a sealed container body and / or a sterile or sterilizable container body. [6] Reaction vessel according to one of the preceding claims, characterized by in that the rotatable foaming element is configured as a disc with mixing elements suitably shaped to create turbulent flow and arranged around an outer periphery of the disc, the mixing elements comprising one or more of the following: vanes, rings, teeth, fins, ribs, wings, arms, fingers, perforated plates, grid structures or an annular coil spring. [7] Reaction vessel according to one of the preceding claims, characterized by that the rotatable foaming element, which is preferably a disc, is configured to be magnetically driven by a magnetic stirrer located outside the foaming chamber and preferably below the lower part of the foaming chamber. [8] Reaction vessel according to one of the preceding claims, characterized by that the rotatable foaming element has a centrally arranged bore, which is preferably open at one end to receive the positioning element. [9] Reaction vessel according to one of the preceding claims, characterized by that the positioning element is a centrally or eccentrically arranged shaft at the bottom of the foaming chamber and preferably has a cylindrical side wall with a rounded upper corner. [10] Reaction vessel according to one of the preceding claims, characterized bythat the reaction vessel further comprises a limiting element for limiting an upward movement of the rotatable foaming element, wherein the limiting element is preferably a rod-shaped element extending from the upper part of the foaming chamber (advantage: it does not fall off the positioning element during transport and handling). [11] Reaction vessel according to one of the preceding claims, characterized by that the deflection element consists of a deflection plate or a deflection body located in the foaming chamber and / or a propeller present on the rotating element. [12] Reaction vessel according to claim 11, characterized byin that the deflection body is a circular ring segment with a trapezoidal basic structure, which has a side bevelled towards the bottom of the foaming chamber and a lower horizontal side which is located above the rotatable foaming element in order to form a gap between the deflection body and the upper edge of the rotatable foaming element, wherein the circular ring segment is preferably attached to the cylindrical wall of the foaming chamber and preferably has a radial ring thickness which substantially covers the mixing elements of the rotatable disc. [13] Reaction vessel according to claim 12, characterized by that the first outlet channel is located below the lower horizontal side of the deflector body. [14] Reaction vessel according to one of claims 2 to 13, characterized by that the container body has a gas distribution system, which preferably consists of: a. a baffle plate or baffle body arranged in the foaming chamber below the first inlet channel to cause a lateral deflection of the gas flow entering the foaming chamber, and b. a hemispherical, conical, frustoconical or dome-shaped upper part of the foaming chamber with the first inlet channel at the top to allow a gas flow that is evenly distributed over the horizontal cross-section of the foaming chamber. [15] Reaction vessel according to one of the preceding claims, characterized bythat the surface of an upper portion of the foaming chamber is coated with a hydrophobic or superhydrophobic agent or is a morphologically structured (super)hydrophobic surface such as a superamphiphobic, a slippery liquid-infused porous surface (SLIPS) or a liquid-impregnated surface (LIS). [16] Cartridge containing: a reaction vessel according to one of claims 1 to 15, b. a foam extraction nozzle comprising a valve and arranged to be accessible from an outside of the cartridge for withdrawing the generated microfoam, and c. a fluid line connecting the first outlet channel of the foaming chamber to the foam discharge nozzle. [17] A cartridge according to claim 16, further comprising: a waste container defining a waste chamber having an inlet for receiving the waste material from the foaming chamber, b. a fluid line connecting the second outlet channel of the foaming chamber to the inlet of the waste container via a valve, and c. wherein the waste container optionally comprises an outlet for pressure relief, wherein the cartridge according to claim 16 comprises a reaction container according to any one of claims 3 to 15. [18] Cartridge according to claim 17, characterized by that the inlet of the waste container is arranged in the upper part of the waste container, preferably as an upper opening of a hollow shaft, which is preferably positioned in the middle of the waste chamber. [19] Cartridge according to claim 17 or 18, characterized bythat the valve for controlling the flow of waste material into the waste chamber is arranged on the outer surface or is accessible from an outer surface of the cartridge and can be controlled by applying external pressure to said valve. [20] Cartridge according to claims 17 to 19, characterized by that the inner surface of the waste chamber is coated with a defoamer or has a morphologically structured defoaming inner surface, for example a defoaming surface, a superamphiphobic surface, a smooth liquid-infused porous surface (SLIPS) or a liquid-impregnated surface (LIS). [21] Cartridge according to claims 17 to 20, characterized by that the cartridge also includes: a. a gas supply nozzle having a sealing element and arranged to be accessible from an outside or located on the outer surface of the cartridge for supplying a gas or gas mixture. b. a fluid line connecting the gas supply port and the first inlet channel of the foaming chamber. [22] Cartridge according to claims 17 to 21, characterized by that the cartridge also includes: a diluent supply port including a sealing element and arranged to be accessible from an outside of the cartridge for supplying an aqueous diluent, b. a fluid line connecting the diluent nozzle and the second inlet channel of the foaming chamber, c. a foaming agent reservoir, which is preferably a syringe and enables a fluid-tight seal with the nozzle of the foaming agent reservoir. [23] Cartridge according to claim 22, characterized by that the cartridge also includes: a foaming agent supply port having a valve and arranged to be accessible from an outside of the cartridge for supplying a foaming agent, b. a fluid line coupling the foaming agent supply port to the foaming agent reservoir port and to the third inlet channel of the foaming chamber, wherein the fluid line comprises a valve that can be positioned to enable fluid communication of the foaming agent reservoir port with the foaming agent supply port or, alternatively, of the foaming agent reservoir port with the third inlet channel, wherein said valve can preferably be switched by applying external pressure to the cartridge. [24] Cartridge according to claims 16 to 23, characterized bythat the cartridge further comprises a means for uniquely identifying the cartridge and / or its properties, which is preferably selected from an RFID transponder, a barcode, a data matrix code, a QR code and a similar code. [25] Automated system for generating microfoam, comprising: a cartridge holder holding a replaceable cartridge according to any one of claims 16 to 24, b. a magnetic stirrer located under the cartridge that generates a rotating magnetic field to control the rotation of the foaming element around the positioning element. [26] Automated system according to claim 25, characterized byin that the cartridge holder has a gas supply nozzle which is configured to come into fluid communication with the gas supply nozzle of the cartridge in the holder, thereby forming a gas-tight seal between both nozzles, wherein the gas supply nozzle or the system preferably has a safety valve which only allows the gas supply when the cartridge is properly locked in the cartridge holder. [27] Automated system according to claim 25 or 26, characterized by in that the cartridge holder has a diluent supply port configured to come into fluid communication with the diluent supply port of the cartridge in the holder, thereby creating a fluid-tight seal between both ports, wherein the diluent supply port or the system preferably includes a safety valve that allows the diluent supply only when a cartridge is properly locked in the cartridge holder. [28] Automated system according to claims 25 to 27, characterized by that the automated system includes a sensor configured to detect, within the cartridge, the presence or flow of a liquid in the fluid line connecting the diluent nozzle and the second inlet channel of the foaming chamber, wherein the sensor is preferably a capacitive sensor or ultrasonic sensor. [29] Automated system according to claims 25 to 28, characterized by that the cartridge holder includes one or more guide elements for properly inserting the cartridge into the cartridge holder, wherein the guide device preferably comprises at least two retractable elements arranged on the bottom of the cartridge holder and fitting onto the respective openings of the cartridge housing. [30] Automated system according to claims 25 to 29, characterized bythat the cartridge holder has a fastening mechanism which is configured to fasten the cartridge to the cartridge holder, wherein the fastening mechanism preferably has one or more elements which are arranged in the side wall of the cartridge holder and can be extended in order to switch on the respective elements of the cartridge housing. [31] Automated system according to claims 25 to 30, characterized by that the automated system has a gas supply system that includes: a. at least one gas nozzle for connection to at least one gas container, preferably a gas cylinder, b. at least one gas line connecting at least one gas nozzle to the gas supply nozzle via a valve for regulating the gas flow, c. optionally a pressure compensation device to compensate for temporary pressure deviations within the foaming chamber. [32] Automated system according to claims 25 to 31, characterized by that the automated system has a gas supply system that includes: a. two gas nozzles for the connection of two gas cylinders containing different gases, preferably mounted in the automatic system and preferably consisting of an O2 gas cylinder and a CO2 gas cylinder, b. a gas duct network between the two gas nozzles and the gas supply nozzle, c. a gas mixing device for mixing the two different gases in a selectable ratio, and d. optionally a pressure compensation device to compensate for temporary pressure deviations within the foaming chamber. [33] Automated system according to claims 25 to 32, characterized by that the automated system has a diluent supply system that includes: a diluent nozzle for connecting a diluent container, preferably mounted in the automatic system, and b. a liquid line connecting the diluent port to the diluent supply port via a pump capable of transporting the diluent from the diluent tank to the diluent supply port. [34] Automated system according to claims 25 to 33, characterized by that the automated system includes a syringe-based dispensing system comprising a drive unit for moving an agitator and capable of performing at least one of the following actions: a. Detecting the correct connection of the inserted syringe with the foam reservoir nozzle of the holding element, b. Detection of complete filling of the syringe via the foam reservoir nozzle by detecting the end position of the piston, c. Dispense a specific amount of foaming agent into the foaming chamber by pressing the plunger of the syringe containing the foaming agent in a controlled manner, d. Optional detection of syringe malfunctions by determining the pressure to be applied to the syringe plunger. [35] Automated system according to one of claims 25 to 34, characterized by that the system further includes: a. a control computer in which the control program is located and which is connected to a user interface for controlling the foaming process, in particular by configuring at least one parameter of the foaming process and / or by initiating the foaming process, wherein at least one parameter is selected directly or indirectly from the following: i. a gas concentration, ii. a mixing ratio of the gas mixture, iii. a concentration of the foaming agent in the mixture of foaming agent and diluent, iv. the total amount of the mixture of foaming agent and diluent, a selection of the liquid composition, v. the rotation speed and duration of the rotating foaming element, vi. removing waste material from the foaming chamber, vii. cleaning the foaming chamber in preparation for the following foaming process, viii. removing the cartridge from the cartridge holder, wherein the automated system is configured to automatically perform the foaming process based on the configured parameter, and in particular to automatically perform the mixing of the gases according to the configured mixing ratio of the gas mixture. [36] A method for automatically generating a microfoam comprising the following steps: a. Providing the reaction vessel according to any one of claims 3 to 15, b. optionally purging the foaming chamber with a selected gas or gas mixture or washing with an aqueous diluent, preferably a saline solution, c. Introducing the selected gas or gas mixture into the foaming chamber via the first inlet channel, d. Introducing a mixture of the foaming agent and the aqueous diluent into the foaming chamber via the second inlet channel, or alternatively introducing the aqueous diluent into the foaming chamber via the second inlet channel and the foaming agent into the foaming chamber via the third inlet channel, e. Rotate the magnetic stirrer to rotate the foaming element until a suitable microfoam is achieved, f. Removal of the achieved therapeutic foam from the foaming chamber via the first outlet channel. [37] A method for automatically producing a microfoam, comprising the following steps: g. Inserting a cartridge according to any one of claims 16 to 24 into the cartridge holder of the automated system according to any one of claims 25 to 35, h. Selecting a foaming agent concentration using a user interface, i. Selecting a ratio for the mixture of two gases using a user interface, j. Filling the foaming agent reservoir by injecting a foaming agent through the sealing element of the foaming agent supply port, k. Starting the foam generation process using a user interface so that the system automatically rotates the magnetic stirrer to rotate the foaming element in the foaming chamber of the cartridge until a suitable microfoam is obtained, 1. Once the foam has been generated, remove the microfoam by pulling on the foam dispensing port of the cartridge, m. optional initiation of a cleaning process of the foaming chamber using a user interface, n. optionally repeating the process according to steps a. to g. [38] A microfoam obtainable by a process according to claim 36 or 37. [39] Microfoam according to claim 38, characterized by that the microfoam has a nitrogen content of less than 2%, preferably less than 1% and particularly preferably less than 0.8%. [40] Microfoam according to claim 38 or 39, characterized by that the microfoam has a number of geometric disturbances which are less than 30% of the number of bubbles, preferably disturbances which are less than 10% of the number of bubbles, and particularly preferably less than 1% of the number of bubbles. [41] Microfoam according to any one of claims 38 to 40, characterized bythat the microfoam has an average bubble size of less than 100 µm, preferably less than 80 µm and particularly preferably less than 50 µm, measured 45 seconds after foam production. [42] Microfoam according to any one of claims 38 to 41, characterized by that the microfoam has an average Sauter radius of less than 200 µm, preferably less than 150 µm and particularly preferably less than 100 µm, measured 45 seconds after foam production. [43] Microfoam according to any one of claims 38 to 42, characterized by that the microfoam has a moisture content of less than 20% by weight and preferably between 8 and 12% by weight. [44] A computer program comprising instructions for performing the steps of claim 36 or 37, which, when executed by a computer, cause the computer to perform the following steps: a. Providing a user interface for controlling a foaming process for generating a microfoam, in particular by configuring at least one parameter of the foaming process and / or by initiating the foaming process, wherein the at least one parameter is selected from the following: a gas concentration, a mixing ratio of the gas mixture, a selection of the liquid composition, a mixing ratio of the agent solution, a concentration of the agent solution in the microfoam and a foaming profile (204), b. Providing at least one graphical element (201) as part of the user interface (200) for selecting or configuring the at least one parameter, c. Providing at least one graphical control element (202) for instructing the computer program, in particular a graphical control element (202) for aborting the computer program and / or a graphical control element (202) for continuing the computer program and / or a graphical control element (202) for going back one step in the computer program, d. Providing at least one graphical section (203) as part of the user interface (200) showing at least one instructive image (205) and / or at least one informative image (206) for instructing or informing a user. [45] Computer program according to claim 44, characterized by that the foam profile (204) comprises at least one of the following parameters: - Profile name and description, - names of the foaming agent, diluent and gases, - List of compatible cartridges, - available selection of agent input concentration, - valid range of the agent input concentration, - Volume of agent to be injected into the cartridge, - available selection of agent concentration in the foam, - available selection of gas ratios, - detailed instructions for preparing the microfoam, - Limit of freshness of the microfoam after production, - Expiry date / use period of the cartridge.
Citation Information
Patent Citations
Micro-Bubble generating device
EP2202782B1
Methods, Devices, Systems and Kits for Preparing Compositions for Care and Repair of Varicose Veins
US20170144115A1
Methods, devices, systems and kits for preparing compositions for care and repair of varicose veins
WO2017085209A1
Solventless silicone pressure sensitive adhesive and methods for making and using same
WO2020000389A1
Improvements relating to the production of foam
GB860883A
